Excerpt from the Handbook of the Chemical Review Committee
Working paper on preparing internal proposals and decision guidance
documents for banned or severely restricted chemicals
Introduction
This document provides guidance to intersessional drafting groups of the Chemical Review Committee (CRC) in
the preparation of decision guidance documents for banned or severely restricted chemicals. It is designed to
clarify the purpose of each section of the decision guidance document and to characterize the information to be
included.
The working paper, originally developed by the interim CRC, was adopted at the first session of the CRC.
Subsequent sessions of the CRC have reviewed and amended this working paper based on the experience gained
in drafting decision guidance documents. This most recent version was adopted by the third session of the CRC
with the understanding that it would continue to evolve in the light of future experience.
Purpose
This working paper is to serve as guidance to drafting groups established by the Chemical Review Committee
for the preparation of decision guidance documents for banned or severely restricted chemicals in accordance
with Article 5 of the Rotterdam Convention.
This working paper is intended:
(a) To clarify the purpose of each section of the decision guidance document;
(b) To characterize the information to be included;
(c) To define acceptable sources of information for each section.
This working paper is expected to evolve as further experience is gained in the preparation of decision guidance
documents. It is to be used by drafting groups preparing decision guidance documents for both pesticides and
industrial chemicals. In this version of the working paper those sections which are potentially different for
industrial chemicals and pesticides have been highlighted. If required, future versions of the working paper may
be split into two separate working documents, one for pesticides and one for industrial chemicals.
A separate working paper has been developed for the preparation of decision guidance documents for severely
hazardous pesticide formulations in accordance with Article 6 of the Rotterdam Convention.
In order to further facilitate the work of the drafting groups an electronic template of a draft decision guidance
document has been prepared as a companion document to this working paper.
General guidance
In preparing each decision guidance document a standard cover/title page will be added as will a version of the
standard introductory text developed at the fourth session of the interim Chemical Review Committee. This text
provides a brief summary of the process through which the individual decision guidance document was
developed and includes three separate sections an introduction, purpose and disclaimer.
In cases where a decision guidance document includes more than one chemical (e.g. asbestos), a table of
contents will facilitate the use of the document. Similarly the insertion of footers identifying the chemical should
be included on each page.
A standard list of “core” abbreviations has been prepared based on experience in drafting decision guidance
documents to date. It is intended that this core list should serve as the basis for decision guidance documents for
both industrial chemicals and pesticides and that it should be augmented by abbreviations used in the individual
decision guidance documents relevant to the chemical(s) in question. This core list of abbreviations is appended
to this working paper (appendix 1). As a general rule it is preferable that acronyms used only once in the text be
spelled out rather than included in the list of abbreviations.
In preparing a decision guidance document, it may be that not all sections are relevant to the chemical under
consideration. It is preferable, in this case, to include a phrase along the lines of ‘not applicable’, rather than
deleting the section or leaving it blank. This clearly indicates that the drafting group had considered that section.
1. Identification and uses
Purpose: To provide an unequivocal identification of the chemical subject to the PIC procedure and its use
as either a pesticide or an industrial chemical, or both.
(a) This basic information should be obtainable from the submitted notifications and the
supporting material available to the Committee prior to its decision to develop a decision
guidance document.
(b) CAS numbers for all forms of the chemical covered in the relevant notifications of final
regulatory action should be included here. The scope of the chemical identified in this
section (chemical description and associated CAS numbers) must be consistent with the
recommendation by the Chemical Review Committee (CRC) for inclusion of the chemical in
Annex III of the Convention. Should additional CAS numbers be found during the
development of the decision guidance document, they should be brought to the attention of
the CRC. If they do not broaden the scope of the original notification, they could be included
here.
(c) Chemical structural formula should be included if practicable. Structural formula may be
found in standard references documents on pesticides e.g. The Pesticide Manual.
Notes: Updated or additional information on trade names, formulation types and basic manufacturers for
products moving in international trade may be identified through the responses to the call for
information on on-going manufacture, use and trade of the chemical.
The list of trade names, formulation types and manufacturers should, where possible, distinguish
old products from those that are known to be moving in international trade.
It is clear that a list of both manufacturers and trade names will be constantly changing, for this
reason a generic disclaimer along the following lines should be considered:
(a) Under trade names:
(b) This is an indicative list of trade names. It is not intended to be exhaustive.
(c) Under basic manufacturers:
This is an indicative list of current and former manufacturers of XXX. It is not intended to be
exhaustive.
In accordance with article 7, when a chemical may be used as both a pesticide and an industrial
chemical (a dual-use chemical), the decision guidance document should provide information on
uses in both categories. A statement on “reported use in X category” or “no reported uses in X
category” should be given (where X is either an industrial chemical for a pesticide decision
guidance document or a pesticide for an industrial chemical).
2. Reasons for inclusion in the PIC procedure
Purpose: To provide a generic statement that clearly identifies the use category (pesticide or industrial
chemical) and whether the chemical is subject to a ban or severe restriction in the notifying
countries.
(a) References to any previous listing(s) under the PIC procedure should also be included,
where relevant.
(b) For dual-use chemicals, it will also be important to note when the PIC obligations do not
apply to the use category that was not regulated.
Example: [Chemical X] is included in the PIC procedure as a pesticide. It is has been listed on the basis of
the final regulatory actions to severely restrict its use, notified by [Country 1], and to ban its use,
notified by [Country 2].
No final regulatory actions relating to industrial chemical uses have been notified.
List notifying countries alphabetically.
2.1. Final regulatory action
Purpose: To provide a brief statement/summary of the final regulatory action(s) as reported by the notifying
countries and the reasons for the actions taken (e.g., occupational health concerns, environmental
concerns).
(a) The text should reflect the reasoning used by the regulatory authority to underpin the
national regulatory action(s) – for example, as presented in national law, regulation, gazette,
legal journal, code.
(b) Specific reference to the relevant directive or regulation for the reported regulatory action(s)
should be included in annex 2.
(c) The reason(s) stated should set the stage for the subsequent description of the underlying risk
evaluation.
National authorities should ensure that any technical legal references, if they are used, are
accurate.
2.2. Risk evaluation
Purpose: To provide a brief summary (no more than 1-2 pages) highlighting the key reported finding(s) of
the national risk evaluation(s) that led to the regulatory action(s).
(a) The text should reflect the reason(s) identified in the final regulatory action(s) by the
notifying countries and include information on the uses that were permitted prior to the
regulatory action.
(b) In the interests of brevity, the text may include references to Convention Annexes I and II
for additional details.
Note: Depending on the chemical and the finding(s) of the national risk evaluations, this section may
provide information on an individual country basis, or, where there are multiple country
notifications based on common human health or environmental concerns, the information may be
summarized and combined. It would also be useful to highlight the differences in regulatory
actions, if they are not already obvious.
3. Protective measures that have been applied concerning the chemical
Purpose: To highlight measures taken to reduce exposure, in the first instance through regulatory controls
or measures and secondly through other measures (administrative, non-legal/voluntary codes of
practice, field practice, etc.) recalling that:
(a) A ban in the regulated category of use eliminates all exposure (occupational or
environmental); and
(b) A severe restriction in the regulated category of use allows continued use in a manner that
reduces risk to an “acceptable” level.
3.1. Regulatory measures to reduce exposure
Purpose: To provide information on the regulatory measures taken to ban or severely restrict the chemical
and associated products.
(a) for bans, the risk has been eliminated and therefore a simple explanation of the risk
management strategy to deal with existing stocks may be enough; and
(b) for severe restrictions, briefly describe the regulatory measures taken/set in place to reduce
the risk to acceptable levels - e.g. by restricting access to trained/certified applicators or
requiring purchasers to be licensed.
3.2. Other measures to reduce exposure
This section is primarily intended for additional information from the notifying country(ies) on chemicals that
have been severely restricted e.g. chemicals where for which virtually all use has been prohibited.
For most banned chemicals this section would not be completed. The exception is where there was relevant
chemical specific information from either the notifying country or international sources on possible risk
mitigation measures.
Purpose: To provide information about non-regulatory measures (including technical and field-level
arrangements) for severely restricted chemicals taken/set in place to reduce exposure and ensure
that risk remains at an acceptable level for the uses that are permitted to continue. Information
could include, for example changing the type of formulation or application equipment used,
specifying the personal protective equipment or clothing required.
Where available, information from the notifying country or international sources of information on
chemical specific risk mitigation measures may also be referenced. Examples may include
publications from the International Labour Organisation or International Standards Organisation.
It is not intended that generic information on handling hazardous chemicals would be included in
this section.
Note: In order to maintain the timeliness and accuracy of this information, it is preferable to include
references to additional sources of information (electronic links, etc) for a specific chemical on the
Rotterdam Convention website. New sources of such information could also be included in a
series of up-dates that could be distributed to designated national authorities along with the PIC
circular.
3.3. Alternatives
Purpose: To provide countries with brief information about alternatives that have been identified by the
notifying country or countries and others where available.
It is not be feasible for the decision guidance document to contain a comprehensive list of specific
pest crop complexes and recommended pesticides or non-chemical alternatives, particularly for
pesticides that have a broad spectrum of activity. As the available alternatives are constantly
evolving, identifying sources of information is likely to be more useful and more reliable than a
list of specific recommendations.
(a) Notifying countries may provide information about chemical and non-chemical alternatives
that are being used within their jurisdictions. Detailed information can be included in annex
2.
(b) Information from sources other than the notifying country might be referenced here with
details on where the information might be found provided to DNAs through the PIC Circular
and the Rotterdam Convention website (see following note).
Note: While recognizing that a range of chemical and non-chemical alternatives may be available, this
section should include a generic statement on the need for caution in considering them or using
them and should remind parties of the need to ensure that they are appropriate to national
circumstances.
In order to maintain the timeliness and accuracy of this information, it is preferable to include
references to additional sources of information (electronic links, etc.) for a specific chemical on
the Rotterdam Convention website. Such new sources of such information could be included in a
series of up-dates that could be distributed to designated national authorities along with the PIC
circular and also used in workshops.
The following is an example of standard text for this section related to pesticides.
There are a number of alternative methods involving chemical and non-chemical strategies,
including alternative technologies available, depending on the individual crop-pest complex under
consideration. Countries should consider promoting, as appropriate, integrated pest management
(IPM) and organic strategies as a means of reducing or eliminating the use of hazardous
pesticides.
Advice may be available through National IPM focal points, the FAO, IFOAM (International
Federation of Organic Movements) and agricultural research or development agencies. Where it
has been made available by governments, additional information on alternatives to XXXX may be
found on the Rotterdam Convention website www.pic.int.
It is essential that before a country considers substituting alternatives, it ensure that the use is
relevant to its national needs and the anticipated local conditions of use. The hazards of the
substitute materials and the controls needed for safe use should also be evaluated.
For industrial chemicals, the final paragraph above should be used, to indicate the need to
consider the hazards associated with possible alternatives. National alternatives should be
included, and if international organisations have discussed alternatives in reviews etc. this
information could also be included.
3.4. Social and economic effects
This section would only be completed where Notifying Countries have undertaken specific studies of the
social and economic effects related to their final regulatory action(s) and wish to report on their findings.
Note: Most countries do not undertake rigorous social and economic studies that are relevant beyond
their own jurisdictions, but they may provide information on alternatives when a country took an
action to restrict a chemical.
This information is optional. When reported, there will need to be a caveat that countries consider
the results of this information in the context of their own national conditions.
4. Hazards and risks to human health and/or the environment
4.1 Hazard Classification
Purpose: To provide a brief summary of internationally recognized classifications applied to the chemical(s)
for which the decision guidance document has been prepared.
(a) This section should focus on internationally recognized standards such as IARC, WHO/IPCS
classification systems.
(i) The standard reference for LD50 values is the most recent edition of the WHO/IPCS
publication, recommended classification of pesticides by hazard and guidelines to
classification. The WHO classification schemes for pesticides as well as its
formulations are based on oral or dermal toxicity. According to the WHO guideline,
the route which indicate greater hazard would be chosen for its classification.
(ii) As far as possible, information on the WHO hazard classification of liquid and solid
formulations should be included.
(b) The US EPA and European Union classification systems have been included as they are
widely used by many countries as a reference.
(c) All references should include the date when they were established.
Note: It is not intended that national standards be included here, notifying countries should include their
national classification schemes in Annex 2.
The following is an example of how this information might be presented:
4. Hazards and Risks to human health and the environment
4.1 Hazard Classification
WHO / IPCS Technical product Insert classification e.g. Class Ia (extremely hazardous)
Classification based on oral or dermal toxicity in rats
a.i.:
LD50: (WHO reference)
Formulations a.i. (%) Hazard class
Liquid
Solid
IARC Group 3: the agent is not classified as to its carcinogenicity to humans. (IARC
reference)
European Classification of the active substance is (Commission Directive reference):
Union
T (toxic)
Xi (Irritant)
N (dangerous for the environment)
R 24/25 (Toxic in contact with skin/ if swallowed)
R 36 (Irritating to eyes)
R 50/53 (Very toxic to aquatic organisms / may cause long-term adverse effects in
the aquatic environment)
US EPA Toxicity Class I (formulation) (EPA reference)
4.2. Exposure limits
Purpose: To provide a brief summary of internationally recognized exposure limits as applied to the
chemical(s) subject to the decision guidance document.
(a) This section should focus on those exposure limits that are internationally recognized, e.g.,
Codex levels in food, WHO drinking water guidelines, etc.
(b) All references should include the date when they were established and the date of any
subsequent review by the FAO/WHO Joint Meeting on Pesticide Residues (JMPR), etc.
(c) It is not intended to capture occupational exposure limits such as Threshold Limit Values
(TLVs) for pesticides largely because of the widely differing ways in which they may be
calculated
Note: It is not intended that national standards be included here as their applicability to other countries is
limited without a good understanding of how the limits were derived. Notifying countries could
include them in Annex 2 if they feel it is appropriate and necessary.
If no international exposure limits are available, the words ‘not applicable for this chemical’ could
be inserted.
4.3 Packaging and labelling
Purpose: To provide a quick reference to existing standards for packaging and labelling of the chemical.
This section should focus on internationally recognized classifications established by the United
Nations Committee of Experts on the Transport of Dangerous Goods, and on the Globally
Harmonized System of Classification and Labelling of Chemicals (if used), the International
Maritime Dangerous Goods Code, etc., along with relevant explanatory text if applicable (i.e. for
specific requirements).
Note: In the case of pesticides, this section should include a generic statement on the availability of
further specific guidance on appropriate symbols and label statements for individual pesticides and
formulations in the FAO Guidelines on Good Labelling Practice for Pesticides.
4.3 Packaging and labelling
The United Nations Committee of Experts on the Transportation of Dangerous Goods classifies the
chemical in:
Hazard Class and Packing Group:
International Maritime Dangerous
Goods (IMDG) Code
Transport Emergency Card
4.4. First aid
Purpose: To provide a quick reference to internationally recognized information on the treatment of
chemical poisoning (pesticides and industrial chemicals) available at the time of publication of the
decision guidance document.
(a) Reference should be generic and include the most recent WHO/IPCS recommendation.
(b) It should note any aspects specific to the chemical cited in the decision guidance document.
(c) A reference to the WHO website for other relevant information might also be included
www.inchem.org
Notes: For chemicals that are not acutely toxic, this section may not be relevant and could be completed
with the statement “not applicable to this chemical”.
Recognizing that a range of first-aid treatments may be available, this section should include a
generic statement on the need for caution and should remind parties of the need to ensure that this
information is in compliance with any national standards that may exist.
4.5. Waste management
Purpose: To ensure that countries are aware of the need for appropriate management of wastes and to
provide references to relevant guidance and other sources of information.
(a) This section should include references to appropriate internationally recognized guidelines
such as those developed by FAO for pesticides.
(b) Particular attention should be drawn to the relevant terms of international agreements – the
Basel Convention on the Control of Transboundary Movements of Hazardous Wastes and
their Disposal.
(c) Notifying countries may wish to note specific actions taken to avoid the creation of
stockpiles, including arrangements to permit use of existing stocks during a phase-out
period.
Annex 1 Further information on the chemical
Annex 1 contains information submitted by the notifying countries based on the national assessments which
were used to support the reported final regulatory action. The results of international reviews such as those of
WHO/IPCS/JMPR/IARC should also be included in this section where available and considered relevant.
Subsequent evaluations or reviews of the chemical from Parties, other than those that submitted the
notifications of final regulatory actions may be submitted to the secretariat for posting on the Rotterdam
Convention website.
Purpose: To provide an overall summary of information on the chemical for which the reported
regulatory action(s) have been taken, including physico-chemical properties of the substance and/or product(s)
and the results of toxicological and ecotoxicity studies. The decision guidance document is not intended to be a
scientific treatise on a chemical. The emphasis should be on the concerns that formed the basis of the reported
final regulatory action(s). For example, if the sole basis of the reported regulatory action(s) is unacceptable
occupational exposure, this annex section should focus on human health effects rather than environmental
aspects.
The principal headings in this annex generally reflect those used by OECD countries and the European Union in
their monographs. This approach will assist all countries, especially developing countries, which may have used
an OECD/European Union monograph as the basis for the risk evaluation supporting their final regulatory
action(s). The generic headings and general guidance on content should facilitate consistency in the format and
content of decision guidance documents.
(a) The introduction to the annex should describe its content. This should include reference to any
relevant international reviews (e.g. those of OECD, IPCS/WHO or IARC) and how this information
has been incorporated into the document. For example whether or not the results of an international
assessment (toxicological or ecotoxicological) are substantively different from those of the notifying
countries should be noted. In the case of mammalian toxicity a summary of the two evaluations
highlighting the similarities or differences as appropriate may be included in section 2.2.7 of this
annex (see below).
(b) The level of detail within the subheadings may be adjusted to accommodate the information used to
support the notified regulatory action and available to the drafting group. (See appendix 2 to the
present note for a list of the headings and subheadings and an indication of the points that may be
included under each.)
(c) Specific sections on exposure/risk evaluation have been included for both human health and
environmental fate and effects. These sections should include specific information from notifying
countries on the basis for their final regulatory action.
General comments
Tabular summaries of information should be used wherever possible; this should not, however, be at the expense
of a clearly stated analysis that explains how the data were used in the risk evaluation that formed the basis for
the reported regulatory action.
The level of detail will be a function of the information that is available and will need to be determined on a
case-by-case basis. As a guiding principle, however, the focus should be on those end points that were the basis
for the risk evaluation underlying the notified final regulatory action. For example, in those instances where a
chemical was found to be a reproductive toxin and this was the basis for the regulatory action, greater detail
would be expected on the supporting studies e.g. NOEL/NOAEL/LOEL, than on end points for which the results
may have been negative (i.e., simply stating “was not carcinogenic”). In the case of universally recognized
regulatory guidelines or limits such as the acceptable daily intake (ADI) or acute reference dose (ARfD), details
on the supporting studies on which they are based should be included.
LD50 and LC50 data can vary widely for a chemical. In order to avoid apparent discrepancies in the information
reported, it may be better to report a range of values wherever possible, particularly where the results from more
than one source are combined.
In reporting toxicity data reference should be made to the duration of exposure for all studies reported, including
acute toxicity studies, where it is available or known.
In some cases, the notifying parties may reach different conclusions on individual end points related to human
health or the environment. Furthermore, the situation may arise where there has been an evaluation of the
chemical at the international level e.g. by the OECD, WHO/IPCS or IARC that has reached conclusions that
differ from those of the findings of the notifying parties. In such cases the following approaches should be
considered:
(a) It is intended that these differences be clearly indicated in the decision guidance document, where
they concern “pivotal end points” within the risk evaluation, that is those end points upon which the
final regulatory action was based.
(b) Where there are differences in interpretation of data concerning specific end points, but the
differences do not affect the outcome of the final regulatory action or the conclusions of the
international review, the degree to which these details will be reflected in the decision guidance
document will need to be considered on a case-by-case basis.
(c) Section 2.2.7 Summary of mammalian toxicity and overall evaluation – this section provides an
opportunity to summarize the conclusions of the toxicological evaluations from the notifying
countries as well as any relevant international reviews e.g. WHO/IPCS/IARC.
Where information from an international evaluation such as an IPCS Environmental Health Criteria document is
included, the reference in the text should be to this document, rather than to the individual papers quoted therein.
Where information from the risk evaluations by the notifying Parties is included, it is sufficient if this source is
indicated, rather than the specific studies or reviews referred to.
Specific comments - details of proposed subheading may be found in appendix 2
1. Physico-chemical properties
This section characterizes the chemical, based on national evaluations and recognized information sources
e.g. Pesticides Manual, A World Compendium (Crop Protection Publications - ISBN 0 948404 79 5)
2. Toxicological properties
2.1. General information
This section should provide brief information on the mode of action, symptoms of poisonings and on
absorption, distribution, excretion and metabolism in mammals. It can be retrieved from the notifications
as well as from internationally recognized sources such as the Pesticide Manual or
WHO/IPCS/JMPR/IARC evaluations.
2.2 Toxicity studies
This section lays out the toxicological profile of the chemical as assessed by the notifying countries at the
time of their final regulatory actions(s). It should also include a comparative summary of any IPCS/WHO
international evaluations, such as those of WHO/IPCS/JMPR, where they are available and considered
relevant. This summary should be included in section 2.2.7 Summary of mammalian toxicity and overall
evaluation.
(a) In the interests of brevity, where multiple studies for the same end point exist, the drafting group
should report in a summary form, rather than report on each individual study. The level of detail will
need to be considered on a case-by-case basis. It is generally accepted that where a review document
has been used as the source of the information, the review document is cited rather than the
individual studies.
(b) Under the heading Summary of mammalian toxicity and overall evaluation (section 2.2.7), the
drafting group should provide a concise summary of key end points, in order to facilitate
comparisons among different evaluations and to improve understanding of those end points
considered in the human exposure/risk evaluation section (see the preceding section on General
comments).
3. Human exposure/risk evaluation
This section highlights in greater detail those human exposure and risk factors that led to the regulatory
control action(s), focusing on the major exposure routes (i.e. food, air, water and occupation).
(a) Information concerning epidemiological studies or poisoning incidents that were considered by the
notifying country in taking the reported regulatory action could be inserted under the subheading
Medical data (section 3.5).
Note: Where the reported regulatory actions are based on environmental effects, it is anticipated that this
section of the decision guidance document would be minimal.
4. Environmental fate and effects
This section provides information on the environmental fate characteristics (Fate, section 4.1) of the
chemical and the results of ecotoxicity studies (Effects on non-target organisms, section 4.2).
Note: Specific subheadings for the parameters of persistence and bio-concentration have been included
to facilitate the identification of chemicals with the characteristics of persistent organic pollutants
(POPs).
5. Environmental exposure/risk evaluation
This section highlights in greater detail those environmental fate factors that led to the regulatory control
action(s) and should include a summary of the overall risk evaluation.
Note: Where the reported regulatory actions are based on human health concerns (e.g., risks to workers),
it is anticipated that this section of the decision guidance document would be minimal.
Annex 2. Details on final regulatory actions reported
Annex 2 reports expand upon the information presented regarding the final regulatory action(s) of each
notifying country.
This annex should reflect the information provided in the notification of regulatory action form and presented to
the Chemical Review Committee for review. The annex represents an opportunity for notifying countries to
provide increased detail on aspects of the regulatory decision that they may wish to include.
Annex 3. Addresses of designated national authorities
This annex should provide detailed information on how to contact the designated national authorities of the
notifying countries, including the name of a contact person; mailing address; telephone, fax and telex numbers;
and email address.
Annex 4. References
This annex includes a list of the sources of information cited in the decision guidance document. Where
information from a review document has been used, the reference should be to the review document, rather than
to the individual papers within the review. Original papers should only be cited where they have been considered
individually, rather than as a component of the review.
List References under headings as appropriate. The following is an example for a reference list:
Regulatory actions
Decision by the Norwegian Agricultural Inspection Service (NAIS) 22.10.2002 (200200430 IP/hmo).
Supporting documentation provided by Country X
Environmental Health Criteria No. 165: Inorganic Lead. IPCS/WHO 1995 (an example of a review document)
Supporting documentation provided by Country Y
Sebastien P, Begin R, & Masse S (1990) Mass number and size of lung fibres in the pathogenesis of asbestosis in
sheep. Int J Exp Pathol, 71: 1-10. (individual paper cited if the original paper was used in the preparation of the
DGD)
Others
WHO (2003): Health Risk of Persistent Organic Pollutants from Long-Range Transboundary Air Pollution.
Relevant guidelines and reference documents
FAO/WHO Food Standards (2010). CODEX Alimentarius.
FAO (2006) Framework of FAO Guidelines on Pesticide Management in support of the Code of Conduct.
http://www.fao.org/ag/AGP/AGPP/Pesticid/Code/Guidelines/Framework.htm
Appendix I: Standard Core Set of Abbreviations1
STANDARD CORE SET OF ABBREVIATIONS
< less than
< less than or equal to
> greater than
> greater than or equal to
µg microgram
m micrometre
ARfD acute reference dose
a.i. active ingredient
ADI acceptable daily intake
AOEL acceptable operator exposure level
b.p. boiling point
bw body weight
o
C degree Celsius (centigrade)
CAS Chemical Abstracts Service
cc cubic centimetre
cm centimetre
DNA deoxyribonucleic acid
DT50 dissipation time 50%
EC European Community
EC50 median effective concentration
ED50 median effective dose
EEC European Economic Community
EHC Environmental Health Criteria
EU European Union
FAO Food and Agriculture Organization of the United Nations
g gram
h hour
ha hectare
i.m. intramuscular
i.p. intraperitoneal
IARC International Agency for Research on Cancer
IC50 median inhibitory concentration
ILO International Labour Organisation
IPCS International Programme on Chemical Safety
IPM Integrated Pest Management
IUPAC International Union of Pure and Applied Chemistry
1 This core list should serve as the basis for DGDs for industrial chemicals, pesticides and severely hazardous
pesticide formulations. It should be augmented by abbreviations used in the individual DGDs relevant to the
chemical(s) in question.
Definitions and spelling should, as far as practicable, follow the IUPAC glossary of terms in toxicology and the
IUPAC glossary of terms relating to pesticides in their current editions.
As a general rule it is preferable that acronyms used only once in the text be spelled out rather than included in
the list of abbreviations.
STANDARD CORE SET OF ABBREVIATIONS
JMPR Joint FAO/WHO Meeting on Pesticide Residues (Joint Meeting of the FAO Panel of Experts on
Pesticide Residues in Food and the Environment and a WHO Expert Group on Pesticide
Residues)
k kilo- (x 1000)
kg kilogram
Koc soil organic partition coefficient
Kow octanol–water partition coefficient
kPa kilopascal
L litre
LC50 median lethal concentration
LD50 median lethal dose
LOAEL lowest-observed-adverse-effect level
LOEL lowest-observed-effect level
m metre
m.p. melting point
mg milligram
ml millilitre
mPa millipascal
MRL maximum residue limit
MTD maximum tolerated dose
ng nanogram
NOAEC no-observed-adverse-effect concentration
NOAEL no-observed-adverse-effect level
NOEC no-observed-effect concentration
NOEL no-observed-effect level
OECD Organisation for Economic Co-operation and Development
PEC predicted environmental concentration
Pow octanol-water partition coefficient, also referred to as Kow
PPE personal protective equipment
ppm parts per million (used only with reference to the concentration of a pesticide in an experimental
diet. In all other contexts the terms mg/kg or mg/L are used).
RfD reference dose (for chronic oral exposure; comparable to ADI)
SMR standard(ized) mortality ratio
STEL short-term exposure limit
TER toxicity exposure ratio
TLV threshold limit value
TWA time-weighted average
UNEP United Nations Environment Programme
USEPA United States Environmental Protection Agency
UV ultraviolet
VOC volatile organic compound
w/w weight for weight
WHO World Health Organization
wt weight
Appendix 2: Headings for Annex I and a list of information points that could be
included under each
1. Physico-chemical properties
2. Toxicological properties
2.1. General
2.1.1. Mode of action
2.1.2. Symptoms of poisoning
2.1.3. Absorption, distribution, excretion and metabolism in mammals
Rate and extent of absorption
Distribution
Potential for accumulation
Rate and extent of excretion
Metabolism in animals
Toxicologically significant compounds (animals, plants and environment)
2.2. Toxicology studies
2.2.1. Acute toxicity
Rat LD50 oral
Rat LD50 dermal
Rat LC50 inhalation
Skin irritation
Eye irritation
Skin sensitization (test method used and result)
2.2.2. Short term toxicity
Target/critical effect
Oral
Dermal
Inhalation
2.2.3. Genotoxicity (including mutagenicity)
2.2.4. Long term toxicity and carcinogenicity
Target/critical effect
Relevant NOAEL/NOEL
Carcinogenicity
2.2.5. Effects on reproduction
Reproduction target/critical effect
Lowest relevant reproductive NOAEL/NOEL
Developmental target/critical effect
Lowest relevant developmental NOAEL / NOEL
2.2.6. Neurotoxicity/delayed neurotoxicity
Acute neurotoxicity
Subchronic neurotoxicity
Special studies (where available)could include human immunotoxicity studies
2.2.7. Summary of mammalian toxicity and overall evaluation
include summary of key findings of relevant international reviews e.g.
WHO/IPCS/IARC evaluations
3. Human exposure/risk evaluation
3.1. Food
3.2. Air
3.3. Water
3.4. Occupational
3.5. Medical data contributing to regulatory decision – could include:
Report on medical surveillance on manufacturing plant personnel
Report on clinical cases and poisoning incidents
Observations on exposure of the general population and epidemiological studies
4. Environmental fate and effects
4.1. Fate
4.1.1. Soil
Field dissipation
Aerobic and anaerobic degradation
Rate of degradation
Adsorption/desorption
Mobility
4.1.2. Water
Route and rate of degradation
4.1.3. Air
Fate and behaviour
4.1.4. Bioconcentration and bioaccumulation
4.1.5. Persistence
4.2. Effects on non-target organisms
4.2.1. Terrestrial vertebrates
Acute/chronic toxicity mammals
Acute/chronic toxicity birds
Dietary toxicity birds
Reproductive toxicity birds
Other
4.2.2. Aquatic species
Fish
Invertebrates
Algal species
Aquatic plants
Other
4.2.3. Honey bees and other arthropods
4.2.4. Earthworms
4.2.5. Soil microorganisms
4.2.6. Terrestrial plants
5. Environmental exposure/risk evaluation
Specific reference as appropriate to the following
5.1. Terrestrial vertebrates
Mammals/birds
5.2. Aquatic species
Fish/invertebrates/algal species/aquatic plants
5.3. Honey bees
Other arthropods
5.4. Earthworms
5.5. Soil microorganisms
5.6. Summary – overall risk evaluation.
ROTTERDAM CONVENTION
Secretariat of the Rotterdam Convention Secretariat of the Rotterdam Convention
United Nations Environment Programme Food and Agriculture Organization of the United Nations
Office Address: International Environment House 1 Viale delle Terme di Caracalla, 00153 Rome, Italy
11–13, chemin des Anémones, 1219 Châtelaine, Geneva, Switzerland Tel.: +39 06 5705 2061 ¦ Fax: +39 06 5705 3224 ¦ E-mail:
[email protected]
Postal Address: c/o Palais des Nations, 8-14, avenue de la Paix, 1211 Geneva 10, Switzerland
Tel.: +41 (0) 22 917 8271 ¦ Fax: +41 (0) 22 917 8098 ¦ E-mail:
[email protected]
Date: 20 February 2019
Subject: Invitation to review and submit comments on the internal proposal of draft decision guidance
document (DGD) for perfluorooctanoic acid (PFOA), its salts and PFOA-related compounds
Dear Sir, Dear Madam,
The fourteenth meeting of the Chemical Review Committee of the Rotterdam Convention was held from 11
to 14 September 2018 in Rome. The report of the meeting (UNEP/FAO/RC/CRC.14/10) is available on the
Convention’s website: http://www.pic.int/tabid/7391/Default.aspx.
At the meeting, the Committee adopted decision CRC-14/5, on perfluorooctanoic acid (PFOA), its salts and
PFOA-related compounds, by which it adopted the rationale for the Committee’s conclusion that the
notifications of final regulatory action submitted by Norway and Canada in respect of those chemicals in the
industrial category met the criteria of Annex II to the Convention as set out in set out in the annex to that
decision.
By the same decision, the Committee recommended, in accordance with paragraph 6 of Article 5 of the
Convention, that the Conference of the Parties list PFOA, its salts and PFOA-related compounds in Annex III
to the Convention as industrial chemicals and decided, in accordance with paragraph 1 of Article 7 of the
Convention, to prepare a draft decision guidance document for those chemicals.
The Committee established an intersessional drafting group to prepare the draft decision guidance document
on PFOA, its salts and PFOA-related compounds. Pursuant to the workplan adopted at the Committee’s
fourteenth meeting (UNEP/FAO/RC/CRC.14/10, annex III), the intersessional drafting group has prepared an
internal proposal of the draft decision guidance document on PFOA, its salts and PFOA-related compounds.
All Parties and observers to the Rotterdam Convention are invited to review the attached internal proposal and
to submit comments to the Committee no later than 29 March 2019.
Submissions are most appreciated in electronic files by e-mail to:
[email protected].
To: Rotterdam Convention official contact points, national focal points
Cc: Representatives of permanent missions to the United Nations Office at Geneva
Secretariat of the Rottei-dam Convention Page 12
For your information, the "working paper on preparing internal proposals and decision guidance documents
for banned and severely restricted chemicals" is enclosed in this letter.
If you have any questions regarding this invitation, please contact Ms. Kei Ohno Woodall, Secretariat of the
Rotterdam Convention (Email:
[email protected]; Tel.: +41 22 917 8201).
Yours sincerely,
Rolph Payet
Executive Secretary
Rotterdam Convention
Operation of the prior informed consent procedure
for banned or severely restricted chemicals
Draft Decision Guidance Document
Perfluorooctanoic acid (PFOA), its salts and
PFOA-related compounds
Secretariat of the Rotterdam Convention
on the Prior Informed Consent Procedure
for Certain Hazardous Chemicals and Pesticides
in International Trade
Introduction
The objective of the Rotterdam Convention is to promote shared responsibility and cooperative efforts among
Parties in the international trade of certain hazardous chemicals in order to protect human health and the
environment from potential harm and to contribute to their environmentally sound use, by facilitating information
exchange about their characteristics, by providing for a national decision-making process on their import and export
and by disseminating these decisions to Parties. The Secretariat of the Convention is provided jointly by the United
Nations Environment Programme (UNEP) and the Food and Agriculture Organization of the United Nations
(FAO).
Candidate chemicals1 for inclusion in the prior informed consent (PIC) procedure under the Rotterdam Convention
include those that have been banned or severely restricted by national regulatory actions in two or more Parties 2 in
two different regions. Inclusion of a chemical in the PIC procedure is based on regulatory actions taken by Parties
that have addressed the risks associated with the chemical by banning or severely restricting it. Other ways might
be available to control or reduce such risks. Inclusion does not, however, imply that all Parties to the Convention
have banned or severely restricted the chemical. For each chemical included in Annex III of the Rotterdam
Convention and subject to the PIC procedure, Parties are requested to make an informed decision whether they
consent or not to the future import of the chemical.
At its […] meeting, held in […] on […], the Conference of the Parties agreed to list perfluorooctanoic acid (PFOA),
its salts and PFOA-related compounds in Annex III of the Convention and adopted the decision-guidance document
with the effect that these chemicals became subject to the PIC procedure.
The present decision-guidance document was communicated to designated national authorities on […], in
accordance with Articles 7 and 10 of the Rotterdam Convention.
Purpose of the decision guidance document
For each chemical included in Annex III of the Rotterdam Convention, a decision-guidance document has been
approved by the Conference of the Parties. Decision-guidance documents are sent to all Parties with a request that
they make a decision regarding future import of the chemical.
Decision-guidance documents are prepared by the Chemical Review Committee. The Committee is a group of
government-designated experts established in line with Article 18 of the Convention, which evaluates candidate
chemicals for possible inclusion in Annex III of the Convention. Decision-guidance documents reflect the
information provided by two or more Parties in support of their national regulatory actions to ban or severely
restrict the chemical. They are not intended as the only source of information on a chemical nor are they updated or
revised following their adoption by the Conference of the Parties.
There may be additional Parties that have taken regulatory actions to ban or severely restrict the chemical and
others that have not banned or severely restricted it. Risk evaluations or information on alternative risk mitigation
measures submitted by such Parties may be found on the Rotterdam Convention website (www.pic.int).
Under Article 14 of the Convention, Parties can exchange scientific, technical, economic and legal information
concerning the chemicals under the scope of the Convention including toxicological, ecotoxicological and safety
information. This information may be provided directly to other Parties or through the Secretariat. Information
provided to the Secretariat will be posted on the Rotterdam Convention website.
Information on the chemical may also be available from other sources.
Disclaimer
The use of trade names in the present document is primarily intended to facilitate the correct identification of the
chemical. It is not intended to imply any approval or disapproval of any particular company. As it is not possible to
include all trade names presently in use, only a number of commonly used and published trade names have been
included in the document.
While the information provided is believed to be accurate according to data available at the time of preparation of
the present decision-guidance document, FAO and UNEP disclaim any responsibility for omissions or any
consequences that may arise there from. Neither FAO nor UNEP shall be liable for any injury, loss, damage or
prejudice of any kind that may be suffered as a result of importing or prohibiting the import of this chemical.
1 According to the Convention, the term “chemical” means a substance, whether by itself or in a mixture or
preparation and whether manufactured or obtained from nature, but does not include any living organism. It
consists of the following categories: pesticide (including severely hazardous pesticide formulations) and
industrial.
2 According to the Convention, the term “Party” means a State or regional economic integration organization
that has consented to be bound by the Convention and for which the Convention is in force.
2
The designations employed and the presentation of material in this publication do not imply the expression of any
opinion whatsoever on the part of FAO or UNEP concerning the legal status of any country, territory, city or area
or of its authorities or concerning the delimitation of its frontiers or boundaries.
3
STANDARD CORE SET OF ABBREVIATIONS
< less than
< less than or equal to
> greater than
> greater than or equal to
µg Microgram
m micrometre
AFFF Aqueous Film Forming Foam
BAF Bioaccumulation factor
BCF Bioconcentration factor
bw body weight
BMDL Benchmark Dose lower confidence bound
BMF Biomagnification factor
BMR Benchmark Response
o
C degree Celsius (centigrade)
CAS Chemical Abstracts Service
cm centimetre
DNA deoxyribose nucleic acid
DT50 dissipation time 50%
DfE Design for the Environment (US EPA program)
dw dry weight
EC European Community
EC50 median effective concentration
ECHA European Chemicals Agency
EEC European Economic Community
EPS Expanded polystyrene
EU European Union
FAO Food and Agriculture Organization of the United Nations
g gram
h hour
IARC International Agency for Research on Cancer
IPCS International Programme on Chemical Safety
IUPAC International Union of Pure and Applied Chemistry
k kilo- (x 1000)
kg kilogram
L litre
LC50 median lethal concentration
LD50 median lethal dose
LOAEL lowest-observed-adverse-effect level
lw liquid weight
m metre
mg milligram
ml millilitre
MAK maximum workplace concentration (Germany)
MW Molecular Weight
NES no effects at saturation
4
STANDARD CORE SET OF ABBREVIATIONS
ng nanogram
NOAEL no-observed-adverse-effect level
NOEC no-observed-effect concentration
NOHSC National Occupational Health and Safety Commission
OECD Organisation for Economic Co-operation and Development
PFAS Per- and Polyfluoroalkyl Substances
PFCA Perfluoroalkyl carboxylic acids
POPRC Persistent Organic Pollutants Review Committee of the Stockholm Convention
PPE personal protective equipment
ppm parts per million (used only with reference to the concentration of a pesticide in an experimental
diet. In all other contexts the terms mg/kg or mg/L are used).
PTFE polytetrafluoroethylene
TH Thyroid hormone
TMF Trophic magnification factor
TSH Thyroid-stimulating hormone
UNEP United Nations Environment Programme
US EPA United States Environmental Protection Agency
w/w weight for weight
WHO World Health Organization
wt weight
wwt Wet weight
5
Decision guidance document for a banned or severely restricted chemical
PERFLUOROOCTANOIC ACID (PFOA), ITS Published:
SALTS AND PFOA-RELATED COMPOUNDS
1. Identification and uses (see Annex 1 for further details)
Common name Perfluorooctanoic acid (PFOA), its salts and PFOA-related compounds
Chemical name and PFOA and its salts and esters;
other names or
synonyms C8; perfluorooctanoate;
pentadecafluoro octanoic acid; perfluoroheptanecarboxylic acid; perfluoro-n-octanoic
acid; Fluorad FC-26; perfluorocaprylic acid;
Perfluorooctanoic acid, which has the molecular formula C7F15CO2H, and its salts.
Compounds that consist of a perfluorinated alkyl group that has the molecular formula
CnF2n+1 in which n = 7 or 8 and that is directly bonded to any chemical moiety other than
a fluorine, chlorine or bromine atom;
Collectively referred to as PFOA.
Octanoic acid, 2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluoro-
Molecular formula C8HF15O2 (PFOA)
Chemical structure
CAS-No.(s) The following PFOA and its related compounds CAS-numbers have been specified in
the notifications from Canada and Norway:
Free Acid (X = OM+; M = H) [CAS no. 335-67-1]
Ammonium Salt (X = OM+; M = NH4) [CAS no. 3825-26-1]
Sodium Salt (X = OM+; M = Na) [CAS no. 335-95-5]
Potassium Salt (X = OM+; M = K) [CAS no. 2395-00-8]
Silver Salt (X = OM+; M = Ag) [CAS no. 335-93-3]
Acid Fluoride (X = F) [CAS no. 335-66-0]
Methyl Ester (X = CH3) [CAS no. 376-27-2]
Ethyl Ester (X = CH2-CH3) [CAS no. 3108-24-5]
Harmonized System 29159070
Customs Code
Other numbers INDEX no: 607-704-00-2
EC no: 206-397-9, EC no: 223-320-4 (ammonium salt); EC no: 206-404-5 (sodium salt)
RTECS no: RH0781000
EINECS# 206-397-9
Category Industrial
Regulated category Industrial chemical
6
Use(s) in regulated Canada:
category Primarily used as water, oil and grease repellants; as surfactants; and as spreading and
wetting agents. AFFFs may also contain APFO [PFOA ammonium salt] as a component
or a contaminant.
Norway:
Used in several applications, i.e. coating agent for carpets, textiles, furniture, shoes,
paper, food wraps, printing plates but also in paint, floor wax, glue and photographic
film. Often PFOA is present in products as a chemical impurity or as trace amounts of
remaining starting materials from the production of other perfluorinated compounds, e.g.
side-chain fluorinated polymers. PFOA has been found in imported products like textiles
treated with perfluorinated compounds in order to make them water and stain repellent.
PFOA may also be found in food contact materials with non-stick properties. PFOA was
previously often present in ski wax in small amounts as a chemical impurity of the
perfluorinated constituents in the wax.
Trade names Not available.
Formulation types Not relevant.
Uses in other Canada and Norway:
categories There was historical use of PFOA as a formulant in some pesticides in Canada which has
recently ceased. Currently, no reported use as a pesticide.
Basic manufacturers 3M, USA (until 2002)
Arkema, Asahi, BASF, Clariant, Daikin, 3M/Dyneon, DuPont and Solvay Solexis
Source: USEPA, 2015
This is an indicative list of known current and former manufacturers. It is not intended to
be exhaustive.
2. Reasons for inclusion in the PIC procedure
Perfluorooctanoic acid (PFOA), its salts and PFOA-related compounds (subsequently referred to as PFOA) are
included in the PIC procedure in the industrial chemical category. PFOA is listed on the basis of final regulatory
actions notified by Canada and Norway that severely restrict its use as an industrial chemical.
2.1 Final regulatory action (see Annex 2 for further details)
Canada:
Regulations that prohibit the manufacture, use, sale, offer for sale or import of PFOA and products containing
PFOA, with a limited number of exemptions. (UNEP/FAO/RC/CRC.14/8 Sections 2 and 2.2.1 of the Canadian
notification).
Reason: Environment
Norway:
Regulations to restrict the production, import, export or sale of consumer products that contain PFOA, its salts and
esters in consumer products if they exceed certain limit values.
(UNEP/FAO/RC/CRC.14/8 Sections 2 and 2.2.1 of the Norwegian notification).
Reason: Human health and the environment
2.2 Risk evaluation (see Annex 1 for further details)
Canada:
An ecological screening assessment was undertaken on perfluorooctanoic acid (PFOA), its salts and its precursors
containing the perfluorinated alkyl moiety (C7F15, C8F17) and is directly bound to any chemical moiety other than a
fluorine, chlorine or bromine atom.
Once in the environment, PFOA is extremely persistent and not known to undergo significant abiotic or biotic
degradation under relevant environmental conditions. PFOA is highly soluble in water and typically present as an
anion (conjugate base) in solution. It has low vapour pressure; therefore, the aquatic environment is expected to be
its primary sink, with some additional partitioning to sediment. The presence of PFOA in the Canadian Arctic is
likely attributable to the long-range transport of PFOA (e.g., via ocean currents) and/or volatile precursors to PFOA
(e.g., via atmospheric transport).
7
PFOA has been detected at trace levels in the northern hemisphere. In North America, higher levels were measured
in surface waters in the vicinity of US fluoropolymer manufacturing facilities (<0.025–1900 μg/L) and in
groundwater near US military bases (not detected [ND] to 6570 μg/L). PFOA was detected in effluent from
Canadian wastewater treatment facilities at concentrations ranging from 0.007 to 0.055 μg/L. PFOA was also
detected in the influent at US wastewater treatment facilities at concentrations ranging from 0.0074–0.089 μg/L.
Trace levels of PFOA have been measured in Canadian freshwater (ND–11.3 μg/L) and freshwater sediments (0.3–
7.5 μg/kg). PFOA has also been detected in a variety of Canadian biota (ND–90 µg/kg wet weight [kg-wwt] tissue)
in southern Ontario and the Canadian Arctic. The highest concentration of PFOA in Canadian organisms was found
in the benthic invertebrate Diporeia hoyi at 90 µg/kg-wwt, followed by turbot liver at 26.5 µg/kg-wwt, polar bear
liver at 13 µg/kg-wwt, caribou liver at 12.2 µg/kg-wwt, ringed seal liver at 8.7 µg/kg-wwt and walrus liver at 5.8
µg/kg-wwt. Following an accidental release of fire-fighting foam in Etobicoke Creek (Ontario), PFOA was
measured in common shiner liver at a maximum concentration of 91 µg/kg-wwt. However, at the time of the
assessment in 2012, PFOA concentrations in Canadian biota (tissue specific and whole body) were below the
highest concentration found in US biota (up to 1934.5 µg/kg-wwt in gar liver).
Temporal or spatial trends in PFOA concentrations in guillemot eggs, lake trout, thick-billed murres, northern
fulmars or ringed seals could not be determined at the time of assessment. However, temporal trends were found for
PFOA concentrations in polar bears (1972 – 2002 and 1984 – 2006) and sea otters (1992 – 2002). PFOA doubling
time in liver tissue was calculated to be 7.3 ± 2.8 years for Baffin Island polar bears and 13.9 ± 14.2 years for
Barrow, Alaska, polar bears; central East Greenland polar bears showed an annual increase of 2.3% in PFOA
concentrations. Concentrations of PFOA also increased significantly over a 10-year period for adult female sea
otters.
Due to the perfluorination, the perfluorinated chains are both oleophobic and hydrophobic. PFOA primarily binds
to albumin proteins in the blood of biota and, as a result, is present in blood and highly perfused tissues such as
liver and kidney, rather than lipid tissue. There is experimental evidence indicating that PFOA is not highly
bioaccumulative in fish. However, these results should not be extrapolated to non-aquatic species, since gills
provide an additional mode of elimination for PFOA that air-breathing organisms, such as terrestrial and marine
mammals, do not possess. Field studies indicating biomagnification factors greater than 1 for the Arctic and other
mammals (such as narwhal, beluga, polar bear, walrus, bottlenose dolphins, and harbor seals) suggest that PFOA
may bioaccumulate and biomagnify in terrestrial and marine mammals. Reported field biomagnification factors for
terrestrial and marine mammals ranged from 0.03–31. Polar bears, as the apex predator in the Arctic marine food
web, have been shown to be the most contaminated with PFOA relative to other Arctic terrestrial organisms.
At the time of the assessment, the risk quotients for pelagic organisms indicated a low likelihood of risk from
exposures at current concentrations in the aquatic environment. The risk quotient for Canadian mammalian wildlife
(i.e., polar bears) is less than 1. However, due to the persistent nature of the substance, its tendency to accumulate
and biomagnify in a variety of terrestrial and marine mammals, its hepatotoxicity, and the upward temporal trend of
PFOA concentrations in polar bears and other species, it was concluded at the time of the assessment that PFOA
concentrations in polar bears may approach exposures resulting in harm.
The assessment was based on a weight of evidence approach regarding persistence, bioaccumulation, temporal
trends in some species (i.e. the polar bear), long-range transport and the widespread occurrence and concentrations
of PFOA in the environment and in biota (including remote areas of Canada). Based on the information presented
in the screening assessment in 2012, it was concluded that PFOA, its salts and its precursors are entering or may be
entering the environment in a quantity or concentration or under conditions that have or may have an immediate or
long-term harmful effect on the environment or its biological diversity.
Norway:
The notification and its supporting material provide a large amount of data relating to human exposure, as well as
information from European Food and Safety Agency document “Perfluorooctane sulfonate (PFOS),
perfluorooctanoic acid (PFOA) and their salts: scientific opinion of the Panel on Contaminants in the Food Chain”
and European Chemicals Agency document “Pentadecafluorooctanoic acid (PFOA) as a substance of very high
concern because of its carcinogenic, mutagenic or toxic for reproduction (CMR) and persistent, bio-accumulating
and toxic (PBT) properties”. The Norwegian studies show that PFOA is transferred from the mother to the fetus,
and that relatively high plasma concentrations are detected in blood samples from small children. Information on
occupational exposure of professional Norwegian ski-waxers, leading to higher PFOA concentrations in blood
serum, is also provided. Information in the risk evaluation points to widespread occurrence and concentrations of
PFOA in the Norwegian environment (air, water and sediment). Persistence, bioaccumulation, temporal trends in
some Arctic species (e.g., the polar bear) and evidence of long-range transport warrant concern.
8
PFOA is a substance of very high concern with respect to its health and environmental properties. PFOA is harmful
to the reproductive system, is carcinogenic, toxic and harmful to human health through repeated exposure, and is
also an irritant. PFOA does not degrade in the environment. PFOA is a PBT substance.
The notification concludes it is impossible to establish an acceptable level for substances with such properties in the
environment, and that emissions and exposure should be limited to the greatest extent possible.
3. Protective measures that have been applied concerning the chemical
3.1 Regulatory measures to reduce exposure
Canada: Perfluorooctanoic acid, which has the molecular formula C7F15CO2H, its salts, and its precursors
(collectively referred to as PFOA) and products containing them are subject to the Prohibition of
Certain Toxic Substances Regulations, 2012 [the Regulations], under the Canadian Environmental
Protection Act, 1999 (CEPA). The Regulations prohibit the import, manufacture, use, sale and offer
for sale of PFOA, and products containing PFOA, with a limited number of exemptions.
The risk management objective for PFOA is to achieve the lowest level of releases into the
Canadian environment which is technically or economically feasible. The prohibitions do not apply
to any toxic substance that is:
a) contained in a hazardous waste, hazardous recyclable material or non-hazardous waste to
which Division 8 of Part 7 of CEPA applies;
b) contained in a pest control product as defined in subsection 2(1) of the Pest Control
Products Act;
c) present as a contaminant in a chemical feedstock that is used in a process from which there
are no releases of the toxic substance and on the condition that the toxic substance is
destroyed or completely converted in that process to a substance that is not a toxic
substance set out in either Schedule 1 or 2 of the regulations; or
d) to be used in a laboratory for analysis, in scientific research or as a laboratory analytical
standard.
The Regulations do not prohibit:
a) The import, manufacture, use, sale and offer for sale of PFOA or a product containing it, if
PFOA is incidentally present [subsection 6(1) of the Regulations]
b) The import, manufacture, use, sale and offer for sale of PFOA or a product containing
them, before January 1, 2017, if it is designed for use in water-based inks or in photo
media coatings, [paragraph 6(2)(b) of the Regulations]
c) The import, use, sale and offer for sale of aqueous film forming foam for fire-fighting
operations that contain PFOA [subsection 6(2.2) of the Regulations]
d) The import, use, sale or offer for sale of manufactured items containing PFOA [subsection
6(2.4) of the Regulations]
e) The use or import of products containing PFOA, if the product is for personal use
[subsection 6(4) of the Regulations].
f) The use, sale or offer for sale of:
a. Products containing PFOA if manufactured or imported before the Regulations
come into force [paragraph 7(2)(a) of the Regulations]
b. Water-based inks and photo media coatings containing PFOA that were
manufactured or imported before January 1, 2017 [subsection 7(1) of the
Regulations]
c. PFOA or products containing it if they were manufactured or imported in
accordance with a permit (section 8 of the Regulations).
(UNEP/FAO/RC/CRC.14/8 Section 2.3.2 of the Canadian notification).
Norway: Since 1 June 2014, it has been prohibited to manufacture, import, export, and sell consumer
products that contain PFOA and individual salts and esters of PFOA (CAS Nos. 335-67-1,
3825-26-1, 335-95-5, 2395-00-8, 335-93-3, 335-66-0, 376-27-2, 3108-24-5), as pure substance or in
9
a mixture when the mixture contains 0.001 per cent or more by weight of the substance.
Furthermore, from 1 June 2014, it has been prohibited to manufacture, import, export and sell
textiles, carpets and other coated consumer products that contain PFOA (CAS Nos. 335-67-1, 3825-
26-1, 335-95-5, 2395-00-8, 335-93-3, 335-66-0, 376-27-2, 3108-24-5), when the content of the
substance in the product's individual parts is greater than or equal to 1 µg/m2. Additionally, from 1
June 2014, it has been prohibited to manufacture, import, export and sell consumer products that
contain PFOA, when the content of the substance in the product's individual parts is greater than or
equal to 0.1 weight percent.
The prohibitions do not apply to food packaging, food contact materials, medical devices, or to
spare parts for consumer products made available for sale prior to 1 June 2014.
(UNEP/FAO/RC/CRC.14/8 Sections 2 and 2.2.1 of the Norwegian notification).
3.2 Other measures to reduce exposure
An overview related to risk reduction approaches for PFASs was provided by OECD. The document includes
information on existing risk reduction approaches in countries including voluntary risk reduction measures taken by
corporations (see pp. 61 to 64 in OECD, 2015). National and/or regional regulations related to PFOA comprise the
following:
a) In 2013, the EU identified both PFOA and its ammonium salt (APFO) as Substances of Very High
Concern (SVHC) due to their persistent, bioaccumulative and toxic properties, and PFOA and APFO were
included into the REACH-Candidate List. On request industry is obliged to inform consumers on the
occurrence to the listed substances in consumer articles if the SVHC in those articles is present in a
concentration of more than 0.1 % (w/w). PFOA/APFO is restricted as a substance or in a mixture for the
supply to consumers according to regulation (EU) 317/2014;
b) PFOA has been included in Annex XVII (restriction) of the REACH regulation within the EU
(Commission regulation (EU) 2017/1000 of 13 June 2017). PFOA shall not be manufactured or placed on
the market as substances on their own from 4 July 2020, or be used in the production of, or placed on the
market in another substance, as a constituent, a mixture, or an article, in a concentration equal to or above
25 ppb of PFOA including its salts or 1 000 ppb of one or a combination of PFOA-related substances. The
restriction includes several exemptions;
c) In the EU, PFOA was included in Annex VI of the Classification, Labelling and Packaging (CLP)
Regulation (Regulation (EC) No 1272/2008), by the Commission Regulation (EU) No 944/2013 of
2 October 2013 (index number: 607-704-00-2);
d) In the US, the United States Environment Protection Agency (USEPA) established the PFOA Stewardship
Programme in 2006. This is a programme that included eight major OECD based manufacturers of PFOA,
its salts and PFOA-related compounds (Arkema, Asahi, BASF, Clariant, Daikin, 3M/Dyneon, DuPont and
Solvay Solexis). The programme was a voluntary initiative to the substantial phase-out the manufacture
and use of PFOA, PFOA precursors and related higher homologue substances (USEPA, 2015). It was
successfully completed at the end of 2015. On 21 January 2015, the USEPA proposed a Significant New
Use Rule under the Toxic Substances Control Act (TSCA) to require manufacturers of PFOA and PFOA-
related chemicals, including as part of articles, and processors of these chemicals to notify USEPA at least
90 days before starting or resuming new uses of these chemicals in any products. This notification would
allow USEPA the opportunity to evaluate the new use and, if necessary, take action to prohibit or limit the
activity.3 While in general, eligible polymers are exempted from the full USEPA new chemical
premanufacture notice and review process, effective 26 January 2010 the USEPA rescinded the exemption
for polymers containing as an integral part of their composition, except as impurities, certain
perfluoroalkyl moieties consisting of a CF3- or longer chain length. This exclusion included polymers that
contain any one or more of the following: perfluoroalkyl sulfonates (PFAS), perfluoroalkyl carboxylates
(PFAC), fluorotelomers, or perfluoroalkyl moieties that are covalently bound to either a carbon or sulfur
atom where the carbon or sulfur atom is an integral part of the polymer molecule;
In China, several national actions were taken in 2011 to restrict new installations of PFOA production
facilities, to eliminate PFOA-containing paints and fluoropolymers that use PFOA in the polymerization
and to encourage the development of alternatives to PFOA. In 2013, fluoropolymer coatings for non-stick
pans, kitchenware and food processing equipment that use PFOA in the polymerization were recognized
as products with high pollution and high environmental risk in the Comprehensive Catalogue for
3 https://www.epa.gov/assessing-and-managing-chemicals-under-tsca/and-polyfluoroalkyl-substances-pfass-
under-tsca.
10
Environmental Protection. In January 2017, new technical requirements for textile products came into
force, in particular establishing limits of PFOA levels to 0.05 mg/kg in coated infant textile products and
to 0.1 mg/kg in all other coated textile products, respectively.
(UNEP/POPS/POPRC.12/11/Add.2 section 2.3.2 of the POPRC Risk Profile)
(UNEP/POPS/POPRC.13/7/Add.2, Chapter 1.4 and 1.5 of the POPRC Risk Management Evaluation)
Stockholm Convention on Persistent Organic Pollutants
Stockholm Convention POPs Review Committee has recommended to the Conference of the Parties that it consider
listing perfluorooctanoic acid (PFOA), its salts and PFOA-related compounds in Annex A to the Convention with
specific exemptions (see UNEP/POPS/POPRC-14/2, UNEP/POPS/POPRC.14/6/Add.2).
3.3 Alternatives
It is essential that before a country considers substituting alternatives, it ensures that the use is relevant to its
national needs, and the anticipated local conditions of use. The hazards of the substitute materials and the controls
needed for safe use should also be evaluated.
Canada:
In Canada, manufacturing has been the main industrial sector using PFOA, specifically, paper and chemical
manufacturing (note PFOA is not manufactured or imported in Canada; however, its salts and precursors have been
reported to be imported). Elsewhere, PFOA has been used in the production of fluoropolymers and fluorotelomers
and as additive and component in consumer and industrial products.
In January 2006, the US EPA introduced a voluntary Stewardship Program to reduce facility emissions and product
content of PFOA and related chemicals on a global basis and to work toward eliminating emissions and product
content of these chemicals by 2015. This Stewardship Program has been a major driver for companies to reduce
residuals in products and to switch from PFOA products to safer alternatives.
The US EPA is also reviewing substitutes for PFOA, PFOS, and other long-chain perfluorinated substances as part
of its review process for new chemicals under EPA's New Chemicals Program. Over 150 alternatives of various
types have been received and reviewed by EPA. Under the US EPA's New Chemical Review of Alternatives for
PFOA and Related Chemicals, shorter chain-length perfluorinated telomeric substances have been notified as
alternatives for a variety of uses including, for example, textile, carpet and paper additive uses, and tile surface
treatments. The major industry users in the global community are moving quickly to replace uses of C-8 and higher
homologues.
Substances which are new to Canada, including new substitutes for PFOA, are subject to the New Substances
provisions of CEPA and the New Substances Notification Regulations. Any company intending to import or
manufacture such a substance must submit a notification, with the substance undergoing an assessment by
Environment Canada and Health Canada to determine whether it meets the definition of "toxic" set out in section 64
of CEPA. Many substitutes to PFOA have been notified to Environment Canada's New Substances Program.
UNEP/FAO/RC/CRC.14/8 section 2.5.3.2 of the Canadian notification
Norway:
US EPA's review of alternatives to perfluorinated chemical substances has been ongoing since 2000 and is
consistent with the approaches to alternatives encouraged under the 2010/15 PFOA Stewardship Program. Through
June 2008, over 100 alternatives of various types have been received and reviewed by EPA.
https://www.epa.gov/assessing-and-managing-chemicals-under-tsca/risk-management-and-polyfluoroalkyl-
substances-pfass#tab-3
Additional information on alternatives could also be found in these two publications:
OECD/UNEP Global PFC Group, 2013.
Wang et al., 2013.
UNEP/FAO/RC/CRC.14/8 section 2.5.3.2 of the Norwegian notification
General:
Several potential alternatives for use in textiles such as short-chain fluorinated alternatives, non-fluorine containing
alternatives and non-chemical alternatives have been identified in the Risk Management Evaluation of
perfluorooctanoic acid (PFOA), its salts and PFOA-related compounds under the Stockholm Convention, including
those that meet regulatory requirements and are in current use. Alternatives to PFOA for manufacture of
polytetrafluoroethylene (PTFE) exist and have been commercialised. Non-fluorinated alternatives and the move to
11
digital imaging have successfully replaced PFOA in the imaging and printing industry. Alternatives to all uses of
PFOA in fire-fighting foams exist and include fluorine-free solutions as well as fluorosurfactants with C6-
fluorotelomers. Fluorine-free foams are comparable to fluorine-based AFFFs and fire-fighting foams with PFOA in
their performance and in meeting relevant certifications for almost all uses. Based on current data, prices of fluorine-
free and fluorine containing aqueous film-foaming foams (AFFFs) are comparable. Some concerns were expressed
about the importance of effective fire-fighting foams for liquid fuel fires, the potential unavailability of suitable
alternatives and the cost of their use and implementation, considering that some time to move to alternatives without
PFASs may be needed. In the USA, non-fluorinated AFFF have been considered to meet the Federal performance
standards and acceptable for use in airports in 2018 (FAA Reauthorization Act of 2018 (HR 302)).
For more information, see chapter 4.2.3 of the POPRC Addendum to the Risk Management Evaluation
UNEP/POPS/POPRC.14/6/Add.2
3.4 Socio-economic effects
Canada:
The scientific evidence has demonstrated that the substance PFOA and its salts are persistent and that they
accumulate and biomagnify in terrestrial and marine animals. The ongoing release of PFOA may result in harm to
the Canadian environment.
The Regulations protect the Canadian environment by preventing the reintroduction of PFOA as industry is already
working towards phasing out these substances.
The Regulations were expected to have a low-cost impact on the industry. The substances were never manufactured
in Canada and are only known to be imported within products or manufactured items. Furthermore, industry sectors
have already completed the transition to alternatives, or were expected to do so prior to the coming into force of the
Regulations. Development of alternatives to PFOA in water-based inks and photo media coatings were underway,
and companies were expected to eliminate their use of these substances by the end of 2016, when the temporary
exemption expired. For aqueous film-forming foams containing PFOA, which are allowed under the Regulations,
the development of alternatives has begun and will be monitored.
UNEP/FAO/RC/CRC.14/8 section 2.5.3.1 of the Canadian notification
Norway:
The regulation proposal may result in some increased costs but will result in significant reductions of the amount of
PFOA introduced into the environment and it will reduce the risk of health and environmental damages. The benefits
are therefore expected to outweigh the costs on the basis of the proposal’s anticipated positive effects for health and
the environment.
UNEP/FAO/RC/CRC.13/8 section 2.5.3.1 of the Norwegian notification
4. Hazards and Risks to human health and the environment
4.1 Hazard Classification
WHO / IPCS Not available.
IARC Possibly carcinogenic to humans (Group 2B).
12
European Harmonised classification - Annex VI of Regulation (EC) No 1272/2008 (CLP Regulation) for
Union PFOA (CAS 335-67-1) (https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-
/discli/details/67229 ):
Acute Tox. 4
-H302 (Harmful if swallowed)
-H332 (Harmful if inhaled)
Eye Dam. 1
-H318 (Causes serious eye damage)
Carc. 2
-H351 (Suspected of causing cancer)
Lact.
-H362 (May cause harm to breast-fed children)
STOT RE 1
-H372 (liver) (Causes damage to organs (liver) through prolonged or repeated exposure)
Repr. 1B
-H360D (May damage the unborn child)
Due to its PBT and CMR properties, PFOA and its ammonium salt (APFO) has been identified as
substances of very high concern (SVHC) under REACH Regulation No 1907/2006 by unanimous
agreement between EU Member States in July 2013.
(UNEP/FAO/RC/CRC.14/8 section 3.1 of the Canadian and Norwegian notifications)
US EPA Not available.
4.2 Exposure limits
Dietary intake including water is considered as the most important route of human exposure to PFOA based on studies
from various countries. Taking this into consideration, among others, the U.S. EPA has issued a lifetime drinking water
Health Advisory for combined PFOA/PFOS of 0.07 micrograms per liter (μg/L) based on a reference dose (RfD)
derived from a developmental toxicity study in mice.
(UNEP/POPS/POPRC.12/11/Add.2 section 2.3.2 of the POPRC Risk Profile)
The European Food and Safety Agency, in their scientific evaluation on the risks to human health related to the
presence of perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) in food, derived a health-based
guidance value that was based on human epidemiological studies. After benchmark modelling of serum levels of
PFOS and PFOA, and estimating the corresponding daily intakes, the CONTAM Panel established a tolerable weekly
intake (TWI) of 6 ng/kg bw per week for PFOA. Exposure of a considerable proportion of the population exceeds the
proposed TWIs.
http://www.efsa.europa.eu/en/efsajournal/pub/5194
https://efsa.onlinelibrary.wiley.com/doi/epdf/10.2903/j.efsa.2018.5194
Occupational exposure limits:
MAK: (inhalable fraction): 0.005 mg/m3; peak limitation category: II(8); skin absorption (H); carcinogen category: 4;
pregnancy risk group: C
Source: International Chemical Safety Card (ICSC) 1613
German Biological Exposure Indices (BEI) 5 mg/l in serum http://gestis-en.itrust.de
4.3 Packaging and labelling
The United Nations Committee of Experts on the Transportation of Dangerous Goods classifies the chemical in:
13
Hazard Class UN #3261
and Packing CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.
Group: UN Hazard Class: 8; UN Pack Group: III
International UN #3261
Maritime CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.
Dangerous
Goods (IMDG)
Code
Transport Transport Emergency Card: TEC (R)-80GC4-II+III
Emergency
Card
4.4 First aid
NOTE: The following advice is based on information available from the World Health Organisation and the
notifying countries and was correct at the time of publication. This advice is provided for information only and
is not intended to supersede any national first aid protocols.
Prevention First Aid
Inhalation Use local exhaust or breathing Fresh air, rest. Artificial respiration may be needed.
protection. Refer for medical attention.
Skin Protective gloves. Protective clothing. Wear protective gloves when administering first aid.
Remove contaminated clothes. Rinse and then wash
skin with water and soap.
Eyes Wear safety goggles or eye protection in Rinse with plenty of water for several minutes (remove
combination with breathing protection if contact lenses if easily possible). Refer immediately for
powder. medical attention.
Ingestion Do not eat, drink, or smoke during work.
Rinse mouth. Give one or two glasses of water to drink.
Refer for medical attention
http://www.inchem.org/documents/icsc/icsc/eics1613.htm International Chemical Safety Card (ICSC) 1613
4.5 Waste management
DISPOSAL: Dispose of as hazardous waste in compliance with local, regional and national regulations. Dispose of
wastes in an approved waste disposal facility.
Annexes
Annex 1 Further information on the substance
Annex 2 Details on final regulatory action reported
Annex 3 Address of designated national authorities
Annex 4 References
14
Annex 1 Further information on the substance
Introductory text to Annex I
The information presented in the present annex reflects the conclusions of the two notifying Parties, namely Canada
and Norway. Where possible, information provided by these two Parties on hazards has been presented together,
while the risk assessments, which are specific to the conditions prevailing in the Parties, are presented separately.
This information is taken from the documents referenced in the notifications in support of the final regulatory
actions relating to PFOA.
The notification from Norway and Canada were first reported in PIC Circular XLI (41) in June 2015 and PIC
Circular XLVII (47) in June 2018, respectively.
The notification from Canada contained a non-exhaustive list of PFOA, its salts and precursors in Annex A. The
notification from Norway specified eight CAS-numbers. The information below refers to perfluorooctanoic acid.
15
Annex 1 – Further information on notified chemical
1 Identity and Physico-Chemical properties
1.1 Identity Octanoic acid, 2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluoro-
(UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile)
1.2 Formula C8HF15O2
(UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile)
1.3 Colour and Texture Solid
(UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile)
1.4 Decomposition temperature Decomposes on heating above 300°C (ICSC 1613)
1.6 Density (g/cm3) Not available.
1.7 Resistance to acids Not available.
1.8 Resistance to alkalis Not available.
1.9 Tensile strength (103 kg/cm2) Not available.
2 Toxicological properties
2.1 General
2.1.1 Mode of Action Data on the mode of action are insufficient
(UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile)
2.1.2 Symptoms of Not available.
poisoning
2.1.3 Absorption, In humans, PFOA is well absorbed by all routes of exposure; it has not been
distribution, demonstrated to be metabolized and has a relatively long half-life. Salts of PFOA
excretion and are expected to dissociate in biological media to produce the perfluorooctanoate
metabolism in (PFO) anion, and are therefore considered toxicologically equivalent to PFOA. Low
mammals concentrations of PFOA have been identified in blood samples from non-
occupationally exposed Canadians, including newborns, indicating environmental
exposure to PFOA and/or compounds that can degrade to PFOA. Canadians are also
potentially exposed to PFOA in utero and through lactational transfer. The relative
contributions of PFOA and its salts and precursors to total PFOA exposure were not
characterized; rather the focus was on aggregate exposure to the moiety of
toxicological concern, PFOA.
(UNEP/FAO/RC/CRC.14/8 Canadian notification)
PFOA is efficiently taken-up by mammals from all exposure routes, and is not
readily eliminated. In humans, half-life is estimated to 2.3 years, but even longer
half-life has been estimated for retired workers from a perfluoroalkyl manufacturing
plant with high plasma PFOA levels. In contrast, half-life values for the monkey,
rat, and mouse are 20.8 days, 11.5 days, and 15.6 days, respectively. PFOA is
transferred to the fetus where it accumulates in the liver, it is also transferred to the
child via breast milk.
Perfluorinated chemicals (PFCs) are amphiphilic. They bind to serum proteins and
proteins in cell membranes, and accumulate in the blood and internal organs such as
liver, kidneys, testes and brain. Metabolic transformation seems to be less important
for elimination. Urine is the primary route of excretion and there are large sex and
species differences in the excretion of PFOA. The reason for the differences in
elimination is likely that PFOA is a substrate for renal organic anion transporters,
regulating active renal reabsorption, and these transporters are differentially
expressed between species and sex.
(UNEP/FAO/RC/CRC.14/8 Norwegian notification)
PFOA is readily absorbed after exposure (ingestion) and accumulates in serum and
highly perfused organs, mainly in the liver and kidney, due to PFOA primarily
16
binding to albumin proteins in the blood. There is evidence that PFOA levels in
humans accumulate and increase with age. PFOA does not undergo metabolism or
biotransformation in the body. As mentioned earlier, the half-life of PFOA
elimination in humans is long, ranging between 2 and 4 years.
PFOA is known to be transmitted to the fetus in cord blood and to the newborn in
breast milk. Developing fetuses and newborns are particularly sensitive to PFOA-
induced toxicity. Positive correlation in PFOA level between maternal and cord
blood samples has been reported in several birth cohort studies in Spain and
Norway. As PFOA can be transferred to infants through breast-feeding, the ECHA’s
Risk Assessment Committee (RAC) agreed on an additional classification of PFOA
on lactation effects (CLP: Lact. H362: May cause harm to breast-fed children).
(UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile)
2.2 Toxicology The toxicity of PFOA has been evaluated by ECHA, US EPA, the Canadian
studies ministries and EFSA. In the European Union, PFOA has a legally-binding
harmonized classification as Carc. 2, Repr. 1B and STOT RE 1 (liver) according to
Regulation (EU) No 944/2013.
(UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile)
Harmonised classification - Annex VI of Regulation (EC) No 1272/2008 (CLP
Regulation) for PFOA (CAS 335-67-1) (https://echa.europa.eu/information-on-
chemicals/cl-inventory-database/-/discli/details/67229 ):
Acute Tox. 4
-H302 (Harmful if swallowed)
-H332 (Harmful if inhaled)
2.2.1 Acute toxicity Toxicity studies in laboratory animals were used to determine the critical effects and
associated serum levels of PFOA. Following oral dosing of PFOA ammonium salt
(APFO), increased liver weight in mice and altered lipid parameters in rats were
observed in short-term (14-day) toxicity studies; increased liver weight was noted in
a 26-week toxicity study in monkeys; and increased liver weight in dams,
alterations in fetal ossification and early puberty in male pups were found in a
developmental toxicity study in mice.
(UNEP/FAO/RC/CRC.14/8 Canadian notification)
PFOA exhibits moderate acute, oral and inhalation toxicity
(UNEP/FAO/RC/CRC.14/8 Norwegian notification)
2.2.2 Short term In sub-acute and chronic studies, PFOA affected primarily the liver and can
toxicity
cause developmental and reproductive toxic effects at relatively low dose levels in
experimental animals. Twenty-eight day oral toxicity studies in rats and mice
showed mortality and dose-related reduced weight gain and increased liver weight
at PFOA dietary concentrations of 30 mg/kg and higher or drinking water
concentrations of 50 mg/L and above.
(UNEP/FAO/RC/CRC.14/8 Norwegian notification)
2.2.3 Genotoxicity PFOA has not been shown to be mutagen. The negative outcome in a
(including comprehensive series of in vitro and in vivo short-term tests at gene and/or
mutagenicity) chromosome level indicates that PFOA is devoid of significant genotoxic activity.
(UNEP/FAO/RC/CRC.14/8 Norwegian notification)
2.2.4 Long term PFOA increased the tumour incidence in rats, mainly in the liver. Based on the
toxicity and weight of evidence at present, the carcinogenic effects in rats appear to be due to
carcinogenicity indirect/non-genotoxic modes of action. PFOA has been shown to induce
hepatocellular adenomas, Leydig cell adenomas and pancreatic acinar cell
hyperplasia in male rats.
(UNEP/FAO/RC/CRC.14/8 Norwegian notification)
In 2-year carcinogenicity bioassays in rats, males administered a high dose of APFO
in the diet had significantly higher incidences of adenomas of the liver hepatocytes,
17
Leydig cells in the testes and pancreatic acinar cells. No evidence of carcinogenic
activity was seen in the female rats. Liver tumours in male rats may be induced via
liver toxicity resulting from PFOA-induced peroxisome proliferation, and additional
pathways secondary to peroxisome proliferation may be involved in the generation
of tumours at other sites. As primates are much less susceptible than rodents to
peroxisome proliferation, the PFOA-induced tumours in male rats are considered to
have little or no relevance for humans. Although blood levels of PFOA were not
determined in the chronic studies, the oral dose of APFO was several times higher
than those in the critical short-term and subchronic studies. Although there is some
evidence to suggest that PFOA may be capable of causing indirect oxidative DNA
damage, the genotoxicity database indicates that PFOA is not mutagenic. Thus, as
the tumours observed in male rats are not considered to have resulted from direct
interaction with genetic material, a threshold approach is used to assess risk to
human health.
(UNEP/FAO/RC/CRC.14/8 Canadian notification)
Animal studies have demonstrated the induction of tumours mediated by PFOA or
APFO, and hepatic activation of the peroxisome proliferator-activated receptor α
(PPARα) has been proposed as a mechanism of induction of hepatic tumours.
However, the PPAR-agonist mode of action proposed for rat liver, testes and
pancreatic tumours may not be relevant for humans. However, human relevance had
not been definitively determined according to established frameworks a decade ago,
and PFOA compounds have also not been tested for carcinogenic potential in any
laboratory animal species other than rats. Therefore, the RAC came to the
conclusion that data on the mode of action are insufficient to conclude that APFO-
induced tumours in animals are not relevant for humans, and therefore, PFOA is
classified as Carc 2. Based on limited evidence in humans that PFOA causes
testicular and renal cancer as well as limited evidence in experimental animals,
IARC has classified PFOA as a Group 2B substance (possibly carcinogenic to
humans).
(UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile)
Findings from studies seem to indicate a PFOA-mediated effect on the endocrine
system. Prenatal exposure of PFOA may alter testosterone concentrations in
females, and an inverse correlation between parathyroid hormone 2 receptor
(PTH2R) and PFOA exposure was also reported in a study of 189 women. As for
men, a study reported an inverse relationship between PFOA serum level in men
and expression of nuclear receptors such as estrogen and androgen receptors. Also,
early menopause in women with high PFOA levels has been observed in the C8
Health Project.
PFOA has been implicated to act as a so-called obesogene similar to other
endocrine disruptive compounds that can act directly on ligands for nuclear
hormone receptors or affect components in metabolic signaling pathways. A human
prospective cohort study showed a correlation between low dose PFOA exposure of
655 Danish pregnant women and obesogenic effects in their offspring at 20 years of
age. Maternal PFOA concentrations were positively associated with serum insulin
and leptin levels and inversely associated with adiponectin levels in female
offspring. On the other hand, the C8 Health Project concluded that PFOA exposure
in early life was not associated with overweight and obesity risk in adulthood.
Evidence from several epidemiological studies seems to suggest an association
between exposure to PFOA and changes in different thyroid hormones leading to
altered thyroid function inducing thyroid disease such as hypothyroidism or
hyperthyroidism. However, there have also been studies that reported inconsistent
findings between PFOA exposure and thyroid diseases (i.e. inverse relation between
subclinical hyperthyroidism and PFOA or no association between hypothyroidism
and PFOA).
The potential of PFOA to affect estrogen receptor (ER) and androgen receptor (AR)
transactivity as well as aromatase enzyme activity was analysed in an in vitro study,
and it was shown that PFOA significantly induced ER transactivity yet antagonized
AR activity in a concentration-dependent manner. In addition, when PFOA was
mixed with 6 other PFCs, a mixture effect more than additive was observed on AR
18
function, emphasizing the importance of considering the combined action of PFCs
in assessing related health risks.
(UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile)
2.2.5 Effects on PFOA has been shown to cause developmental and reproductive toxic effects at
reproduction relatively low dose levels in experimental animals. Several studies observed
complete litter loss at doses of 5 mg/kg bw/day. Increased postnatal pup mortality,
decreased pup body weight and delayed sexual maturation were observed in several
mice studies. A two generation reproductive toxicity study in rats has shown post-
weaning mortality, reduced growth, and delayed sexual maturation. Follow-up
developmental toxicity studies in mice have shown a pattern of neonatal mortality
similar to that observed in mice; this consists of a dose-related increase in mortality
during the first several days after birth. Cross-fostering studies have shown that the
critical period of exposure is during the prenatal period. Further studies have shown
delayed development of the mammary glands in both the dams and female offspring
with systemic toxicity in rodents and monkeys following long-term exposure by the
oral route.
(UNEP/FAO/RC/CRC.14/8, Norwegian notification)
2.2.6 Neurotoxicity/ Impaired neurodevelopment has been associated with PFOA. An inverse
delayed relationship between prenatal PFOA concentrations in mothers and
neurotoxicity, neurodevelopment as determined with the mental development index (MDI) in
Special studies female (not male) offspring at 6 months of age was observed in a Japanese birth
where available cohort (Hokkaido) study. However, this relationship was not observed with
offspring at 18 months of age. Also, no correlation between PFOA levels and birth
weight was observed in the same cohort study. Statistically significant inverse
associations between PFOA and memory impairment has been reported. On the
other hand, there are studies that reported no association between PFOA exposure
and impaired neurodevelopment or behavior.
(UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile)
2.2.7 Summary of PFOA is classified as Carc. 2, Repr. 1B and STOT RE 1 (liver) according to
mammalian Regulation (EU) No 944/2013. IARC also categorised PFOA as a Group 2B
toxicity and substance (possibly carcinogenic to humans). There have been reported adverse
overall health effects such as elevated cholesterol levels, altered
evaluation reproductive/developmental effects, endocrine disruption, impaired
neurodevelopment, as well as increased risk of cancer associated with PFOA
exposure in humans. Scientific data have demonstrated PFOA-mediated
immunotoxicity, primarily suppression of antibody response, in humans. Although
the findings are limited, the reported adverse health effects suggest additional public
health concerns.
(UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile)
3 Human exposure/Risk evaluation
3.1 Food Human exposure typically takes place “human via environment” by consumption of
drinking water and food, via uptake of contaminated indoor dust or from consumer
products containing PFOA and its related substances. PFOA has been detected in
humans in blood and breast milk from various countries. Babies are susceptible to
PFOA exposure via breastfeeding or trans-placental passage, and people who live
near fluoropolymer manufacturing facilities have been shown to have higher levels
of serum PFOA than those from the general population.
The available data indicate that Canadians are exposed to PFOA and its precursors
in the environment, including via air, drinking water and food; and from the use of
consumer products, such as new non-stick cookware and perfluorinated compound
(PFC)-treated apparel and household materials such as carpets and upholstery.
(UNEP/FAO/RC/CRC.14/8, Canadian notification)
3.2 Air PFOA has been detected in the air of remote areas
(UNEP/POPS/POPRC.12/11/Add.2), as well as household dust (Shoeib et al., 2011)
and airborne particulate matter (Yu et al., 2018).
19
3.3 Water Human PFOA exposure occurs via dietary intake of food and drinking water,
exposure to contaminated indoor dust or consumer products containing PFOA and
its related substances. Studies have demonstrated the presence of PFOA within
humans, mainly in blood and breast milk samples. Fetuses and newborns are
susceptible to PFOA exposure via breastfeeding or trans-placental passage.
Occupational exposure or exposure near sites of production resulted in higher serum
PFOA levels than exposure of general population.
(UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile)
3.4 Occupational There are a few reports of detected PFOA serum levels in the occupationally
exposure exposed workers. Indoor dust and total suspended particles seem to be important
occupational exposure routes in fluorochemical manufacturing and is also
considered relevant in domestic settings. In some cases, elevated serum PFOA
levels can be largely attributed to exposure to PFOA-related compounds such as 8:2
FTOH. Persons living in the vicinity of fluorochemical manufacturing plants have
higher PFOA levels than the general population.
(UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile)
3.5 Medical data Not available.
contributing to
regulatory
decision
3.6 Public exposure Analysis of serum samples demonstrate that PFOA is detectable across the general
population in various countries.
(UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile)
3.7 Summary- The Norwegian notification and its supporting material provide a large amount of
overall risk data relating to human exposure, as well as information from European Food and
evaluation Safety Agency document “Perfluorooctane sulfonate (PFOS), perfluorooctanoic
acid (PFOA) and their salts: scientific opinion of the Panel on Contaminants in the
Food Chain” and European Chemicals Agency document “Pentadecafluorooctanoic
acid (PFOA) as a substance of very high concern because of its CMR and PBT
properties”. The Norwegian studies show that PFOA is transferred from the mother
to the fetus, and that relatively high plasma concentrations are detected in blood
samples from small children. Information on occupational exposure of professional
Norwegian ski-waxers, leading to higher PFOA concentrations in blood serum, is
also provided. Information in the risk evaluation points to widespread occurrence
and concentrations of PFOA in the Norwegian environment (air, water and
sediment). Persistence, bioaccumulation, temporal trends in some Arctic species
(e.g., the polar bear) and evidence of long-range transport warrant concern.
PFOA is a substance of very high concern with respect to its health and
environmental properties. PFOA is harmful to the reproductive system, is
carcinogenic, toxic and harmful to human health through repeated exposure, and is
also an irritant. PFOA does not degrade in the environment. PFOA is a persistent,
bio-accumulating and toxic (PBT) substance.
The notification concludes it is impossible to establish an acceptable level for
substances with such properties in the environment, and that emissions and
exposure should be limited to the greatest extent possible.
(UNEP/FAO/RC/CRC.14/8, Norwegian notification)
4 Environmental fate and effects
4.1 Fate Once in the environment, PFOA is extremely persistent and not known to undergo
significant abiotic or biotic degradation under relevant environmental conditions.
(UNEP/FAO/RC/CRC.14/8, Canadian notification)
4.1.1 Soil Based on high persistence, it was not possible to calculate half-lives in soil or
sediment.
(UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile)
20
4.1.2 Water PFOA is highly soluble in water and typically present as an anion (conjugate base)
in solution. It has low vapour pressure; therefore, the aquatic environment is
expected to be its primary sink, with some additional partitioning to sediment.
(UNEP/FAO/RC/CRC.14/8, Canadian notification)
4.1.3 Air On the basis of the available data, abiotic degradation of PFOA in the atmosphere is
expected to be slow. The atmospheric lifetime of PFOA has been predicted to be
130 days (conclusion by analogy from short-chain perfluorinated acids).
(UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile)
4.1.4 Bioconcentration PFOA does not seem to bio-concentrate in water-breathing animals. The high water
solubility of PFOA enables fish to quickly excrete this substance via gill
permeation, facilitated by the high water throughput.
In air-breathing animals, PFOA has been found in terrestrial species as well as in
endangered species as polar bear and in animals that may become endangered in
near future (such as narwhal and beluga whale). Once taken up in the body, PFOA
tends to partition to liver and blood.
BMFs range from 1.3 – 125 for selected predator prey relationship
TMFs range from 1.1 – 13 for selected food chains.
(UNEP/FAO/RC/CRC.14/8, Norwegian notification)
The assessment of bioaccumulation for PFOA is complicated by its physical
properties, which make assessment of log Kow, BCF and BAF approaches
challenging. PFOA does not accumulate in water-breathing animals according to
the criteria of the Stockholm Convention. This can be explained by the way that
fish process and excrete PFOA through their gills.
PFOA biomagnifies in air breathing mammals. PFOA has been detected within the
body tissues of air-breathing aquatic species. For terrestrial species, the presence of
PFOA is readily detected, with a number of studies indicating BMF and TMF
scores of greater than 1. There is evidence that PFOA bioaccumulates in air-
breathing mammals and other terrestrial species, including humans.
(UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile)
4.1.5 Persistence PFOA is extremely stable within the natural environment due to its chemical
properties and does not degrade under environmentally relevant conditions.
Based on the available experimental evidence it is concluded that PFOA is highly
persistent in all environmental compartments, with a strong resistance to all
conventional mechanisms of degradation under relevant environmental conditions.
Within the aquatic compartment under natural environmental conditions, PFOA has
a half-life of greater than 92 years with the most likely value of 235 years and
shows no obvious decay from photodegradation. In aquatic environments where
PFOA undergoes indirect photolysis, the half-life was estimated to be longer than
349 days.
(UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile)
4.2 Effects on non-
target organisms
4.2.1 Terrestrial The potential impact of exposure to perfluorinated compounds on liver lesions was
vertebrates investigated in East Greenland polar bears. Liver parameters examined included
mononuclear cell infiltrations, lipid granulomas, steatosis, Ito cells and bile duct
hyperplasia/portal fibrosis. The population consisted of 28 females and 29 males
harvested by local hunters between 1999 and 2002. Liver samples were analyzed
for PFOS, perfluorononanoic acid, perfluoroundecanoic acid, perfluorodecanoic
acid, perfluorotetradecanoic acid, PFOA, perfluorooctanesulfonamide,
perfluorodecanoate and perfluorohexanesulfonate. In 23 cases, the concentration of
PFOA was below the detection limit (0.0012 µg/g-wwt). Liver samples were also
analyzed for several perfluorinated compound including C9, C10, C11, C12 and
C13 PFCAs. Sixty-five percent of the polar bears had total PFA concentrations
above 1 µg/g-wwt. In female bears, the total PFAS concentration ranged from
0.256 to 2.77 µg/g-wwt; in male bears, the total PFAS concentration ranged from
21
0.114 to 3.052 µg/g-wwt. All PFAS compounds in the analysis were summed, so a
direct cause–effect correlation with a particular perfluorinated compound, such as
PFOA, cannot be determined. East Greenland polar bears are also contaminated
with other substances, such as organochlorines (polychlorinated biphenyls [PCBs],
dichlorodiphenyltrichloroethane [DDT]) and mercury, which may function as
confounding synergistic co-factors in the development of the lesions. The authors
concluded that the statistical analysis did not answer the question of whether
chronic exposure to perfluorinated compounds is associated with liver lesions in
polar bears; however, these lesions were similar to those produced by
perfluorinated compounds under laboratory conditions.
(UNEP/FAO/RC/CRC.14/8, Canadian notification)
There is experimental evidence in terrestrial organisms showing the potential for
PFOA to induce alterations to the liver, endocrine dysfunction, developmental
toxicity and tumour formation. Adverse effects include alterations in sexual
maturation and pubertal timing, changes in mammary gland development as well as
induction of a variety of tumours. There are some indications of
PFOA-mediated immunomodulation. Because of the tendency of PFOA to
bioaccumulate, PFOA concentrations in polar bears might increase over time and
approach exposures resulting in harm.
(UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile)
4.2.2 Aquatic species In traditional toxicity studies, PFOA exhibits moderate to low acute toxicities in
pelagic organisms, including fish (70–2470 mg/L). PFOA exhibits low chronic
toxicities in benthic organisms (>100 mg/L). There is one study on the toxicity of
PFOA and its salts in avian wildlife. In this study, PFOA was found to have no
effect on embryonic pipping success for white leghorn chickens at concentrations
up to 10 µg/g of embryos. However, PFOA accumulated in the liver of these
embryos to concentrations 2.9 – 4.5 times greater than the initial whole-egg
concentration.
A study examined freshwater male tilapia (Oreochromis niloticus) as the in vitro
model to detect the induction of vitellogenin. Vitellogenin is an egg yolk precursor
protein expressed in females of fish, amphibians, reptiles (including birds), insects
and the platypus. In the presence of substances that affect endocrine function, males
can also express the vitellogenin gene. Cultured male tilapia hepatocytes were
exposed to PFOA, 4:2 FTOH, 6:2 FTOH and 8:2 FTOH for 48 hours. A dose-
dependent induction of vitellogenin was observed in PFOA- and 6:2 FTOH–treated
cells, whereas vitellogenin remained unchanged for 4:2 FTOH and 8:2 FTOH. The
estimated 48-hour median effective concentration (EC50) values were 2.9 × 10 –5 M
(12 mg/L) for PFOA and 2.8 × 10–5 M (12.9 mg/L) for 6:2 FTOH. In the time
course study, vitellogenin induction took place at 48 hours (PFOA), 72 hours (4:2
FTOH), 12 hours (6:2 FTOH) and 72 hours (8:2 FTOH) and increased further after
96 hours of exposure. Co-exposure to a mixture of individual perfluorinated
compounds and 17β-estradiol for 48 hours significantly inhibited 17β-estradiol-
induced hepatocellular vitellogenin production in a dose-dependent manner, except
for 4:2 FTOH. The estimated 48-hour median inhibitory concentration (IC50)
values were 5.1 × 10–7 M(0.21 mg/L) for PFOA, 1.1 × 10–6 M (0.51 mg/L) for 6:2
FTOH and 7.5 × 10–7 M (0.35 mg/L) for 8:2 FTOH. In order to further investigate
the estrogenic mechanism, the hepatocytes were co-exposed to a mixture of PFOA
and 6:2 FTOH plus the known estrogen receptor inhibitor tamoxifen for 48 hours.
The overall results demonstrated that PFOA and FTOHs have estrogenic activities
and that exposure to a combination of 17β-estradiol and PFOA or FTOHs produces
anti-estrogenic effects. The results of the estrogen receptor inhibition assay further
suggested that the estrogenic effect of PFOA and FTOHs may be mediated by the
estrogen receptor pathway in primary cultured tilapia hepatocytes. A study assessed
the effects of PFOA on male and female rare minnows (Gobiocypris rarus) at
concentrations of 3, 10 and 30 mg/L for 28 days. Exposure to PFOA at 3 mg/L
elicited moderate hepatocellular hypertrophy in the livers of both male and female
fish. Male rare minnows exposed to PFOA at 10 mg/L showed eosinophilic hyaline
droplets in the cytoplasm of the hepatocytes; female rare minnows displayed more
eosinophilic hyaline droplets in the cytoplasm of the hepatocytes, hepatocellular
hypertrophy and vacuolar degeneration. Rare minnows exposed to PFOA at 30
22
mg/L showed severe hepatic histopathological changes and disruption of
mitochondrial functions. The inhibition of the thyroid hormone biosynthesis genes
and the induction of estrogen-responsive genes may indicate a role in endocrine
function. Another study further identified the potential protein biomarkers for
PFOA exposure in the livers of the rare minnows at 3, 10 and 30 mg/L for 28 days,
finding the abundance of 34 and 48 protein spots altered in males and females,
respectively. These proteins were involved in intracellular fatty acid transport,
oxidative stress, macromolecule catabolism, the cell cycle, maintenance of
intracellular Ca2+ homeostasis and mitochondrial function. In another article, the
authors studied the in vivo effects of waterborne PFOA on the expression of hepatic
estrogen-responsive genes, vitellogenin, and estrogen receptor and on the gonadal
development in freshwater rare minnow (Gobiocypris rarus). The study showed
mature females exposed to 3, 10, and 30 mg/L PFOA for 28 days had degenerating
vitellogenic-stage oocytes (atresia) in the ovaries. In males exposed to 10 mg/L
PFOA, primary growth–stage oocytes (pre-vitellogenic oocytes) developed in some
testes. The number of sperm and various stages of germ cells within the
spermatogenic cycle in the 10 and 30 mg/L PFOA treatments were lower than those
in control males. PFOA increased hepatic vitellogenin concentration and induced
testis-ova gonads in mature male rare minnows at 10 and 30 mg/L for 28 days. It
was shown that PFOA can disrupt the activity of estrogen by inducing hepatic
estrogen-responsive genes in males, although the mechanism of development of
testes-ova in rare minnows by PFOA exposure is not known.
The toxicity of PFOA was examined with respect to the multixenobiotic resistance
mechanism in the marine mussel, Mytilus californianus. This mechanism acts as a
cellular first line of defence against broad classes of xenobiotics exporting
moderately hydrophobic chemicals from cells via adenosine triphosphate (ATP)–
dependent, transmembrane transport proteins. The most studied transporter is the P-
glycoprotein, which is a fragile defence mechanism and can be compromised by
some xenobiotics. This increased sensitivity, referred to as chemosensitization,
arises from the ability of the P-glycoprotein to recognize and bind to multiple
xenobiotic substrates, resulting in the saturation of the binding capacity. Non-toxic
substances can also be chemosensitizers and cause adverse effects on organisms by
allowing normally excluded toxic substances to accumulate in the cell. PFOA at
50 µM (20 mg/L) was found to significantly inhibit the P-glycoprotein in Mytilus
californianus and thus is a chemosensitizer for that organism. The study also
showed that this inhibition was reversible once the marine mussel was removed
from contamination and placed in clean seawater.
The effect of PFOA on immune function and clinical blood parameters has been
examined in bottlenose dolphins and sea turtles from Florida, Georgia and South
Carolina. It should be noted that a direct cause–effect relationship cannot be clearly
established, as there may be other co-occurring contaminants. The results revealed
that there may be increases in indicators of inflammation and immunity in
bottlenose dolphin blood parameters in relation to PFOA, suggesting that PFOA
may alter biomarkers of health in marine mammals. Examples of biomarkers
analyzed in bottlenose dolphins include absolute numbers of lymphocytes, serum
triglyceride, serum total protein, serum albumin, serum cortisol, C-reactive protein,
lysozyme activity and B-cell proliferation. Serum triglyceride exhibited stronger
relationships to PFOA in females than in males. Lipopolysaccharide-induced
lymphocyte proliferation (B-cell proliferation) had positive but weak correlations
with PFOA in male bottlenose dolphins, and a strong correlation was observed
between PFOA and lysozyme activity (a measurement of innate immunity) in the
same species. However, in another study, no correlations were found between any
perfluorinated compound, including PFOA, and blood chemistry parameters (e.g.
cholesterol, creatinine, albumin, total serum ion etc.) for the northern fur seal
(Callorhinus ursinus).
Low levels of PFAs may also alter biomarkers of health in loggerhead sea turtles.
Examples of biomarkers analyzed in loggerhead sea turtles include plasma total
protein, plasma globulin, T-cell proliferation, plasma lysozyme activity and B-cell
proliferation.
(UNEP/FAO/RC/CRC.14/8, Canadian notification)
23
Acute aquatic toxicity is low in standard ecotoxicity tests; moderate to low acute
toxicities are seen in pelagic organisms including fish and low chronic toxicities in
benthic organisms. Adverse effects include intergenerational toxicity in the first
offspring generation and some PFOA-mediated toxicity in freshwater algae and
other aquatic organisms.
(UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile)
4.2.3 Honeybees and Not available.
other arthropods
4.2.4 Earthworms Not available.
4.2.5 Soil The soil-dwelling nematode Caenorhabditis elegans has been shown to be a
microorganisms suitable test organism, showing both lethal and sublethal effects, in the
ecotoxicological assessments of liquid and soil media. Acute lethal toxicity and
multigenerational sublethal toxicity (fecundity and reproduction) were examined
using PFOA concentrations of 0, 0.01 mM (4.14 mg/L), 0.1 mM (41.4 mg/L), 0.5
mM (207 mg/L), 1.0 mM (414.07 mg/L) and 5.0 mM (2100 mg/L) for 48 hours. All
concentrations up to 0.1 mM (41.4 mg/L) showed no acute lethality until 48 hours.
Acute lethality appeared at concentrations greater than 0.5 mM (207 mg/L) and did
not depend on the incubation time. EC50s were calculated for 1 hour (3.85 mM or
1590 mg/L), 2 hours (2.80 mM or 1160 mg/L), 3 hours (2.70 mM or 1120 mg/L), 4
hours (2.65 mM or 1100 mg/L), 24 hours (2.75 mM or 1140 mg/L) and 48 hours
(2.35 mM or 973 mg/L). In the multi-generational test, generation–response and
concentration–response relationships were not observed for PFOA.
(Government of Canada, 2012a)
4.2.6 Terrestrial In seed germination and 5-day root elongation toxicity tests on lettuce (Lactuca
plants sativa), cucumber (Cucumis sativus) and pakchoi (Brassica rapa chinensis), PFOA
had no effect on cucumber seed germination, with both LC50 and NOEC values
greater than 2000 mg/L. The LC50 and NOEC values for lettuce seed germination
were 1734 and 1000 mg/L, respectively. The LC50 and NOEC values for pakchoi
seed germination were 579 and 250 mg/L, respectively. The EC 50 for root
elongation for the three species ranged from 263 to 1254 mg/L. PFOA almost
completely inhibited lettuce and pakchoi root growth at or above 1000 mg/L.
NOECs for root elongation for the three species ranged from <62.5 to 250 mg/L.
In a study on the soil-to-plant carryover of a mixture of PFOA/PFOS on spring
wheat, oats, potatoes, maize, and perennial ryegrass. Concentrations ranged from
0.25 to 50 mg/kg of PFOA/PFOS as an aqueous solution. PFOA concentrations
were higher than PFOS in all plants except for potatoes with uptake/storage more
intensive in the vegetative portion than the storage organ. Visible abnormalities
were noted at concentrations > 10 mg/kg. At 25 – 50 mg/kg PFOA/PFOS, necrosis
was observed in both oats and potatoes, a yellowing of the ryegrass leaves, and
diminished growth for spring wheat.
(Government of Canada, 2012a)
In plants, PFOA can cause visible abnormalities and alter root growth.
(UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile).
5 Environmental Exposure/Risk Evaluation
5.1 Terrestrial Temporal trends were found for PFOA concentrations in polar bears (1972 – 2002
vertebrates and 1984 – 2006) and sea otters (1992 – 2002). PFOA doubling time in liver tissue
was calculated to be 7.3 ± 2.8 years for Baffin Island polar bears and 13.9 ± 14.2
years for Barrow, Alaska, polar bears; central East Greenland polar bears showed
an annual increase of 2.3% in PFOA concentrations. Concentrations of PFOA also
increased significantly over a 10-year period for adult female sea otters.
The risk quotient for Canadian mammalian wildlife (i.e., polar bears) is less than 1;
however, due to the persistence of the substance, its tendency to accumulate and
biomagnify in a variety of terrestrial and marine mammals, its hepatotoxicity, and
the upward temporal trend of PFOA concentrations in polar bears and some other
species, PFOA concentrations in polar bears may approach exposures resulting in
harm. The assessment is based on a weight of evidence approach regarding
24
persistence, bioaccumulation, temporal trends in some species (i.e. the polar bear),
long-range transport and the widespread occurrence and concentrations of PFOA in
the environment and in biota (including remote areas of Canada). Based on the
information presented in the screening assessment, it is concluded that PFOA, its
salts and its precursors are entering or may be entering the environment in a
quantity or concentration or under conditions that have or may have an immediate
or long-term harmful effect on the environment or its biological diversity.
(UNEP/FAO/RC/CRC.14/8, Canadian notification)
The notification concludes it is impossible to establish an acceptable level for
substances [like PFOA] with such properties in the environment, and that emissions
and exposure should be limited to the greatest extent possible.
(UNEP/FAO/RC/CRC.14/8, Norwegian notification)
5.2 Aquatic species Trace levels of PFOA have been measured in Canadian freshwater (ND–11.3 μg/L)
and freshwater sediments (0.3–7.5 μg/kg). PFOA has also been detected in a variety
of Canadian biota (ND–90 µg/kg wet weight [kg-ww] tissue) in southern Ontario
and the Canadian Arctic. The risk quotients for pelagic organisms indicate a low
likelihood of risk from exposures at current concentrations in the aquatic
environment.
(UNEP/FAO/RC/CRC.14/8, Canadian notification)
The notification concludes it is impossible to establish an acceptable level for
substances [like PFOA] with such properties in the environment, and that emissions
and exposure should be limited to the greatest extent possible.
(UNEP/FAO/RC/CRC.14/8, Norwegian notification)
5.3 Honey bees Not available.
5.4 Earthworms Not available.
5.5 Soil Not available.
microorganisms
5.6 Summary – Based on the available experimental evidence, it is concluded that PFOA is highly
overall risk stable and persistent within the natural environment. PFOA is unlikely to degrade
evaluation under conditions present in the natural environment and has been shown to have
long half-lives within the environment. Monitoring data show that PFOA in soil
leaches over time and can be a long-term contamination source to underlying
groundwater.
PFOA has been found in marine, limnetic and terrestrial biota worldwide, and
bioaccumulation of PFOA occurs across trophic levels. Assessment of
bioaccumulation for PFOA is complicated by its physical properties as a surfactant,
which make analysis for development of log Kow values not directly possible.
PFOA accumulates and biomagnifies in air breathing animals and other terrestrial
species including humans but not in water breathing animals as fish excrete PFOA
through their gills.
Monitoring of water, snow, air, sediment and biota at remote locations all detect the
presence of PFOA. Equally, environmental modeling data and other information
enable to conclude that PFOA meets the criterion for long range transport.
PFOA exhibits adverse effects for both terrestrial and aquatic species. Ecotoxicity
data indicate a low acute toxicity for aquatic organisms. There is also experimental
evidence in terrestrial organisms showing the potential for PFOA to induce changes
in liver function, endocrine function, development as well as immune responses,
and induction of tumours has been shown in rats exposed to PFOA. The adverse
effects of PFOA in biota have not yet been elucidated, but because of the tendency
of PFOA to bioaccumulate, PFOA concentrations in biota, especially polar bears,
might increase over time and approach exposures resulting in harm.
(UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile Chapter 3)
25
Annex 2 – Details on final regulatory actions reported
Country Name: Canada
1 Effective date(s) of December 23, 2016.
entry into force of
actions
Reference to the Prohibition of Certain Toxic Substances Regulations, 2012 (SOR/2012-285), as
regulatory amended, 2016 (SOR/2016-252) under the Canadian Environmental Protection Act,
document 1999 (CEPA).
http://www.gazette.gc.ca/rp-pr/p2/2016/2016-10-05/html/sor-dors252-eng.html
2 Succinct details of Perfluorooctanoic acid, which has the molecular formula C7F15CO2H, its salts, and its
the final precursors (collectively referred to as PFOA) and products containing them are
regulatory subject to the Prohibition of Certain Toxic Substances Regulations, 2012 (the
action(s) Regulations) as amended in 2016, under the Canadian Environmental Protection Act,
1999 (CEPA).
The Prohibition of Certain Toxic Substances Regulations, 2012 prohibit the import,
manufacture, use, sale and offer for sale of PFOA, and products containing PFOA,
with a limited number of exemptions.
3 Reasons for action The regulatory action was based on concerns related to the environment.
4 Basis for inclusion The regulatory action was taken to protect environment. The regulatory action was
into Annex III based on a risk evaluation taking into account the prevailing conditions in Canada.
The screening assessment, on which the regulatory action in based on and that was
performed in Canada
(http://www.ec.gc.ca/ese-ees/default.asp?lanq=En&n=370AB133-1) makes use of the
extensive information on uses, releases and environmental levels of PFOA in Canada,
including the Canadian Arctic.
4.1 Risk evaluation The assessment is based on a weight of evidence approach regarding persistence,
bioaccumulation, temporal trends in some species (i.e. the polar bear), long-range
transport and the widespread occurrence and concentrations of PFOA in the
environment and in biota (including remote areas of Canada). Based on the
information presented in the screening assessment, it is concluded that PFOA, its salts
and its precursors are entering or may be entering the environment in a quantity or
concentration or under conditions that have or may have an immediate or long-term
harmful effect on the environment or its biological diversity.
(UNEP/FAO/RC/CRC.14/8 Canadian notification)
4.2 Criteria used Risk to environment.
Relevance to other The notification states that, once in the environment, PFOA is extremely persistent
States and Region and not known to undergo significant abiotic or biotic degradation under relevant
environmental conditions. PFOA is highly soluble in water and typically present as an
anion (conjugate base) in solution. It has low vapour pressure; therefore, the aquatic
environment is expected to be its primary sink, with some additional partitioning to
sediment. The presence of PFOA in the Canadian Arctic is likely attributable to the
long-range transport of PFOA (e.g., via ocean currents) and/or volatile precursors to
PFOA (e.g., via atmospheric transport).
PFOA has been detected at trace levels in the northern hemisphere. The notification
states that a number of countries and organizations (including the European Union,
Norway, the United States of America, the Stockholm Convention on Persistent
Organic Pollutants and the Protocol to the United Nations Economic Commission for
Europe Convention on Long-Range Transboundary Air Pollution of 1979) either have
put in place or are proposing management measures to control the manufacture,
import, use and releases of perfluoroalkyl substances (PFAS) and manufactured
products containing PFAS.
26
Given the hazards and long-range transport of this substance as described in the
screening assessment on which the regulatory action is based, any state or region in
which exposure or release is possible may find the regulatory action relevant.
5 Alternatives In January 2006, the US EPA introduced a voluntary Stewardship Program to reduce
facility emissions and product content of PFOA and related chemicals on a global
basis and to work toward eliminating emissions and product content of these
chemicals by 2015. This Stewardship Program has been a major driver for companies
to reduce residuals in products and to switch from PFOA products to safer
alternatives.
The US EPA is also reviewing substitutes for PFOA, PFOS, and other long-chain
perfluorinated substances as part of its review process for new chemicals under EPA's
New Chemicals Program. Over 150 alternatives of various types have been received
and reviewed by EPA. Under the US EPA’s New Chemical Review of Alternatives
for PFOA and Related Chemicals, shorter chain-length perfluorinated telomeric
substances have been notified as alternatives for a variety of uses including, for
example, textile, carpet and paper additive uses and tile surface treatments. The major
industry users in the global community are moving quickly to replace uses of C-8 and
higher homologues.
(UNEP/FAO/RC/CRC.14/8 Canadian notification)
6 Waste The notifying Party did not provide information on waste management of PFOA or
management articles containing it.
7 Other None.
27
Country Name: Norway
1 Effective date(s) of 1 June 2014
entry into force of
actions
Reference to the PFOA and its salts and esters are regulated by Chapter 2-32 of the Regulation related
regulatory to restrictions of the manufacture, import and placing on the market of chemicals and
document other products hazardous to the human health and the environment (Product
Regulation). Act no. 922 of June 2004.
2 Succinct details of Regulations to restrict the production, import, export or sale of consumer products
the final that contain PFOA, its salts and esters in consumer products if they exceed certain
regulatory limit values. The prohibition om manufacture and export did not apply until 1 January
action(s) 2016 to a) adhesives, foil and tape in semiconductors, and b) photographic coatings of
film, paper and printing plate. The prohibition on import and sale did not apply until 1
January 2018 to products for which it could be documented that the manufacture took
place prior to prohibitions in mentioned above came into force.
3 Reasons for action The regulatory action was based on concerns related to human health and the
environment.
4 Basis for inclusion The final regulatory action was taken to protect human health and the environment.
into Annex III The regulatory action was based on a risk evaluation taking into account the
prevailing conditions in Norway.
4.1 Risk evaluation In the Norwegian “Evaluation of consequences of regulating PFOA and selected salts
and esters of PFOA in consumer products”, the following concerns were put forward
for the proposed regulation: PFOA is present in the blood of the general population,
breast milk and in umbilical cord blood. PFOA is eliminated from the body very
slowly. Humans are exposed to PFOA by consuming contaminated foods or water, by
breathing air that is polluted as well as by ingesting dust. Fish is an important source
of exposure via food. The fetus is exposed to PFOA via umbilical cord blood and
newborns are exposed via breast milk. The intake for infants via breast milk can be
greater than the intake via food for adults. Infants can also come into direct contact
through carpeting, and swallowing dust can be an important contributor to exposure.
PFOA is a substance of very high concern with respect to its health and
environmental properties. PFOA is harmful to the reproductive system, carcinogenic,
toxic and harmful to human health through repeated exposure and is also an irritant.
PFOA does not degrade in the environment. PFOA is a substance similar to
persistent, bio-accumulating and toxic (PBT) substances or a substance of equal
concern. It is impossible to establish an acceptable level for substances with such
properties in the environment, and emissions and exposure should be limited to the
greatest extent possible.
(UNEP/FAO/RC/CRC.14/8 Norwegian notification)
4.2 Criteria used Risk to human health and the environment.
Relevance to other The notification states that concerns similar to those identified in Norway are likely to
States and Region be encountered in other countries where the substance is used. PFOA is present in
various globally distributed products. Adaptation of manufacturing methods to meet
the Norwegian requirements may lead to reduced levels of PFOA in products in other
countries as well. Several textile brands have phased out the use of perfluorinated
compounds for water repellence treatment because of the negative attention directed
at such compounds by various stakeholders.
The notification also cites Norway’s “Evaluation of consequences of regulating
PFOA and selected salts and esters of PFOA in consumer products”, according to
which PFOA is transported long distances via air and sea currents, and its presence
has been detected in the Arctic in a variety of species, including sea birds, seals and
polar bears. The substance has also been identified as CMR and PBT, which are
relevant concerns for any state or region in which PFOA may be released.
5 Alternatives EPA's review of alternatives to perfluorinated chemical substances has been ongoing
since 2000 and is consistent with the approaches to alternatives encouraged under the
28
2010/15 PFOA Stewardship Program. Through June 2008, over 100 alternatives of
various types have been received and reviewed by EPA.
https://www.epa.gov/assessing-and-managing-chemicals-under-tsca/fact-sheet-
20102015-pfoa-stewardship-program
Additional information on alternatives could also be found in these two publications:
OECD/UNEP Global PFC Group, Synthesis paper on per- and polyfluorinated
chemicals (PFCs), 2013.
Wang, Z., Cousins, I.T., Scheringer, M., Hungerbühler, K., 2013. Fluorinated
alternatives to long-chain perfluoroalkyl carboxylic acids (PFCAs), perfluoroalkane
sulfonic acids (PFSAs) and their potential precursors. Environ Int 60, 242-248
(UNEP/FAO/RC/CRC.14/8 Norwegian notification)
6 Waste The notifying Party did not provide information on waste management of PFOA or
management articles containing it.
7 Other None.
29
Annex 3 – Addresses of designated national authorities
Canada
C
From PIC website (18 December, 2018): Phone: +1 819 420 8047
Name: Ms. Nathalie Morin Fax: +1 819 938 4218
Job title: Director Email:
[email protected]
Department: Chemical Production Division
Institution: Environment and Climate Change Canada
Postal address: 351 St. Joseph Boulevard
K1A OH3 Gatineau
Québec
Canada
Norway
C
From PIC website (18 December, 2018):
Name: Ms. Trine Celius Phone: +47 735 80 500
Job title: Senior Advisor Rotterdam Convention Designated Fax: +47 735 80 501
National Authority for Industrial Chemicals and Biocides Email:
[email protected],
Institution: Norwegian Environment Agency
[email protected]
Postal address: Grensesvingen 7
0661 Oslo
Norway
Name: Ms. Christel Moræus Olsen Phone: +47 735 80 500
Job title: Senior Advisor, Rotterdam Convention Designated Fax: +47 735 80 501
National Authority for Industrial Chemicals and Biocides Email:
[email protected],
Department: Section for Biocides and Declaration of
[email protected]
Chemicals/ Chemicals and Waste Department
Institution: Norwegian Environment Agency
Postal address: Grensesvingen 7
0661 Oslo
Norway
C Industrial chemicals
CP Pesticides and industrial chemicals
30
Annex 4 – References
Regulatory actions
Canada
Prohibition of Certain Toxic Substances Regulations, 2012 (SOR/2012-285), as amended, 2016 (SOR/2016-252)
under the Canadian Environmental Protection Act, 1999 (CEPA).
http://www.gazette.gc.ca/rp-pr/p2/2016/2016-10-05/html/sor-dors252-eng.html
Norway
Chapter 2-32 of the Regulation related to restrictions of the manufacture, import and placing on the market of
chemicals and other products hazardous to the human health and the environment (Product Regulation). Act no.
922 of June 2004.
Supporting documentation provided by Canada
Government of Canada. August 2012a. Screening Assessment Report on Perfluorooctanoic Acid, Its Salts
and Its Precursors. http://www.ec.gc.ca/ese-ees/default.asp?lang=En&n=370AB133-1
Government of Canada. August 2012b. Proposed Risk Management Approach for Perfluorooctanoic
Acid (PFOA), its Salts, and its Precursors and Long-Chain (C9-C20) Perfluorocarboxylic Acids (PFCAs),
their Salts, and their Precursors. http://www.ec.gc.ca/ese-ees/default.asp?lang=En&n=451C95ED-1
Environment Canada and Health Canada. October 2016. Regulatory Impact Analysis Statement,
Regulations Amending the Prohibition of Certain Toxic Substances Regulations, 2012.
http://www.gazette.gc.ca/rp-pr/p2/2016/2016-10-05/html/sor-dors252-eng.html
Supporting documentation provided by Norway
PFOA in Norway; Survey on national sources, TA-2354/2007. Available online at:
http://www.miljodirektoratet.no/old/klif/publikasjoner/2354/ta2354.pdf
Per- and polyfluorinated substances in the Nordic Countries Use, occurrence and toxicology TemaNord
2013:542
Perfluorinated alkylated substances (PFAS) in the Nordic environment. TemaNord 2004:552
Impact assessment of regulating perfluorooctanoic acid (PFOA) and individual PFOA salts and esters in
consumer products. The Norwegian version is available online: «Vurdering av konsekvenser av regulering
av PFOA og enkelte salter og estere av PFOA i forbrukerprodukter”.
http://www.miljodirektoratet.no/Global/dokumenter/horinger/horing2010-1463_PFOA.pdf
Perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA) and their salts. Scientific Opinion of the
Panel on Contaminants in the Food chain. The EFSA Journal 2008, 653, 16-131
ECHA: Pentadecafluorooctanoic acid (PFOA) as a substance of very high concern because of its CMR
and PBT properties. 14 June 2013.
Fromme, H.; Mosch, C.; Morovitz, M.; Alba-Alejandre, I.; Boehmer, S.; Kiranoglu, M.; Faber, F.;
Hannibal, I.; Genzel-Boroviczény, O.; Koletzko, B.; Völkel, W. Pre- and postnatal exposure to
perfluorinated compounds (PFCs). Environ Sci Technol 2010, 44, 7123–7129.
Thomsen, C.; Haug, L. S.; Stigum, H.; Frøshaug, M.; Broadwell, S. L.; Becher, G. Changes in
concentrations of perfluorinated compounds, polybrominated diphenyl ethers, and polychlorinated
biphenyls in Norwegian breast-milk during twelve months of lactation. Environ Sci Technol 2010, 44,
9550–9556.
Haug, L.S., Salihovic, S., Jogsten, I.E., Thomsen, C., van Bavel, B., Lindström, G., Becher,G. 2010a.
Levels in food and beverages and daily intake of fluorinated compounds in Norway. Chemosphere, 80,
1137–1143.
Haug, L.S., Thomsen, C., Brantsæter, A.L., Kvalem, H.E., Haugen, M., Becker, G., Alexander, J.,
Meltzer, H.M., Knutsen, H.K. 2010b. Diet and particulary seafood are major sources of perfluorinated
compounds in humans. Environ. Int., 36, 772–778.
31
Haug, L.S., Huber, S., Becher, G., Thomsen, C. 2011. Characterisation of human exposure pathways to
perfluorinated compounds – comparing exposure estimates with biomarkers of exposure. Environ Int 37,
687–693.
Granum B, Haug LS, Namork E, Stølevik SB, Thomsen C, Aaberge IS, van Loveren H, Løvik M,
Nygaard UC. Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine
antibody levels and immune-related healthoutcomes in early childhood. J Immunotoxicol. 2013,10:373-9.
Daae et al 2009: Kjemisk eksponering og effekter på luftveiene blant profesjonelle skismørere, ISSN nr.
1502-0932
Smithwick M, Norstrom R.J., Mabury S.A., Solomon K., Evans T.J., Stirling I., Taylor M.K., Muir D.C.G.
2006. Temporal trends of perfluoroalkyl contaminants in polar bears (Ursus maritimus) from two locations
in the North American arctic, 1972-2002. Environ. Sci. Technol. 40(4):1139-1143.
Dietz et al. 2008; “Increasing Perfluoroalkyl Contaminants in East Greenland Polar Bears (Ursus
maritimus): A New Toxic Threat to the Arctic Bears”, Environ. Sci. Technol. 2008, 42, 2701–2707
Tom Erik Økland and Kristina Skoog; TA-2450/2008. Available online at:
http://www.miljodirektoratet.no/old/klif/publikasjoner/2450/ta2450.pdf
Aquateam, 2010. Undersøkelse av miljøgifter ved fire norske renseanlegg: PFOA, Bisfenol A, Triklosan,
Siloksan (D5), Dodecylfenol og 2,4,6-Tri-tert.betylfenol. [Study of priority substances in four Norwegian
processing plants: PFOA, Bisphenol A, Triclosan, Siloksan (D5), Dodecylfenol og 2,4,6-Tri-
tert.betylphenol] Klif TA 2636/2010. Available online at:
http://www.miljodirektoratet.no/old/klif/publikasjoner/2636/ta2636.pdf
Evenset et al. 2005: Miljøgifter i marine sedimenter, Isfjorden, Svalbard. [Priority substances in marine
sediments, Isfjordenm Svalbard.] Akvaplan-NIVA-rapport APN-414. 3341.
Bakke, T., Fjeld, E., Skaare, B., Berge. J.A., Green, N., Ruus, A., Schlabach, M., and Botnen, H., 2007.
Kartlegging av metaller og utvalgte nye organiske miljøgifter 2006. Krom, arsen, perfluoralkylstoffer,
dikloretan, klorbenzener, pentaklorfenol, HCBD og DEHP. [Mapping out of metals and select new organic
environmental toxins 2006; Chromium, arsenic, perfluoroalkyl substances, dichloroethane,
chlorobenzenes, pentachlorophenol, HCBD and DEHP] SFT TA2284/2007. NIVA report 5464-2007.
105s.
Manø S, Herzke D, Schlabach M, Nye miljøgifter i luft [New priority substances in air] (TA-2408/2008).
Available online at: http://www.miljodirektoratet.no/old/klif/publikasjoner/2408/ta2408.pdf
AMAP, 2009. Arctic Pollution 2009 (POPs, Human Health, Radioactivity). Arctic Monitoring and
Assessment Programme (AMAP), Oslo, Norway. xi+83 pp
OECD/UNEP Global PFC Group, Synthesis paper on per- and polyfluorinated chemicals (PFCs), 2013.
Wang, Z., Cousins, I.T., Scheringer, M., Hungerbühler, K., 2013. Fluorinated alternatives to long-chain
perfluoroalkyl carboxylic acids (PFCAs), perfluoroalkane sulfonic acids (PFSAs) and their potential
precursors. Environ Int 60, 242-248
IFA, Institut fur Arbeitsscultz der Deutschen Gesetzlichen Unfallversicherung (http://gestis-
en.itrust.de/nxt/gateway.dll/gestis_en/493012.xml?f=templates$fn=default.htm$3.0)
ECHA, 2014. Annex XV Restriction Report: Proposal For a Restriction - Perfluorooctanoic acid
(PFOA), PFOA salts and PFOA - related substances
http://echa.europa.eu/documents/10162/e9cddee6-3164-473d-b590-8fcf9caa50e7
Perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA) and their salts. Scientific Opinion of the
Panel on Contaminants in the Food chain. The EFSA Journal 2008, 653, 16-131.
ECHA, E.C.A., 2008. Summary Of Classification and Labelling: Harmonised classification – Annex VI of
Regulation (EC) No 1272/2008 (CLP Regulation) – PFOS. vol. 2012.
(ECHA), E.C.A., 2011. Opinions of the Committee for Risk Assessment on proposals for harmonised
classification and labelling – PFOA. vol. 2012.
ECHA/RAC/CLH report 2011. Annex 1, Background document to the Opinion proposing harmonised
classification and labelling at Community level of Perfluorooctanoic acid (PFOA).
OECD, 2006, SIDS Initial Assessment Report PFOA.
32
Environment Canada (2012): Screening Assessment Report; Perfluorooctanic Acid, its Salts, and its
Precursors.
Verreault J, Berger U, Gabrielsen GW. 2007. Trends of perfluorinated alkyl substances in herring gull
eggs from two coastal colonies in northern Norway: 1983–2003. Environ Sci Technol 41(19): 6671–6677.
Bytingsvik J, van Leeuwen SP, Hamers T, Swart K, Aars J, Lie E, Nilsen EM, Wiig O, Derocher AE,
Jenssen BM. Perfluoroalkyl substances in polar bear mother-cub pairs: a comparative study based on
plasma levels from 1998 and 2008. Environ Int. 2012, 49:92-9.
Other Documents
UNEP/POPS/POPRC.12/11/Add.2. (2016). Risk profile on pentadecafluorooctanoic acid (CAS No: 335-67-1,
PFOA, perfluorooctanoic acid), its salts and PFOA-related compounds.
UNEP/POPS/POPRC.13/7/Add.2 (2017). Risk management evaluation on pentadecafluorooctanoic acid (CAS No:
335-67-1, PFOA, perfluorooctanoic acid), its salts and PFOA-related compounds.
UNEP/POPS/POPRC-14/2. (2018) Report of the Persistent Organic Pollutants Review Committee on the work of
its fourteenth meeting.
UNEP/POPS/POPRC.14/6/Add.2 (2018). Addendum to the risk management evaluation on perfluorooctanoic acid
(PFOA), its salts and PFOA-related compounds.
Schoeib, M., Harner, T., Webster, G.M., Lee, S.C., 2011. Indoor Sources of Poly- and Perfluorinated Compounds
(PFCS) in Vancouver, Canada: Implications for Human Exposure. Environ. Sci. Technol. 2011, 45, 19, 7999-
8005. https://pubs.acs.org/doi/pdf/10.1021/es103562v)
Yu, N., Guo, H., Yang, J., Jin, L., Wang X.,, Shi, W., Zhang, X., Yu, X., Wei, S. 2018. Non-Target and Suspect
Screening of Per- and Polyfluoroalkyl Substances in Airborne Particulate Matter in China. Environ. Sci. Technol.
2018, 52, 8205−8214
Relevant guidelines and reference documents
IPCS (2017): PERFLUOROOCTANOIC ACID. International Chemical Safety Card (ICSC) 1413. Available at:
http://www.ilo.org/dyn/icsc/showcard.display?p_version=2&p_card_id=1613
United Nations (2013): UN Recommendations on the Transport of Dangerous Goods - Model Regulations,
Eighteenth revised edition. Available at: http://www.unece.org/trans/danger/publi/unrec/rev18/18files_e.html
IMO (2016): International Maritime Dangerous Goods Code (IMDG Code). Available at:
http://www.imo.org/en/Publications/IMDGCode/Pages/Default.aspx
33
Saatja: Kei Ohno Woodall <
[email protected]>
Saadetud: 25.02.2019 16:52
Adressaat: Kei Ohno Woodall <
[email protected]>
Teema: Rotterdam Convention - Invitation for comments on PFOA, its salts
and PFOA-related compounds draft DGD internal proposal
Tähtsus: Kõrgeim
Dear Sir/Madam,
Please find attached a letter inviting comments on the internal proposal
of draft decision guidance document (DGD) for perfluorooctanoic acid
(PFOA), its salts and PFOA-related compounds.
The fourteenth meeting of the Chemical Review Committee was held from 11
to 14 September 2018 in Rome. The meeting report is available on the
Conventions website: . At the meeting, the Committee adopted decision
CRC-14/5, by which it adopted the rationale for the Committees conclusion
that the notifications of final regulatory action submitted by Norway and
Canada in respect of those chemicals in the industrial category met the
criteria of Annex II to the Convention, and recommended that the
Conference of the Parties list PFOA, its salts and PFOA-related compounds
in Annex III to the Convention as industrial chemicals.
Pursuant to the workplan adopted by the Committee (UNEP/FAO/RC/CRC.14/10,
annex III), the intersessional drafting group has prepared an internal
proposal of the draft DGD on PFOA, its salts and PFOA-related compounds.
You are invited to review the attached draft and submit your comments by
e-mail to before 29 March 2019.
The "working paper on preparing internal proposals and decision guidance
documents for banned and severely restricted chemicals" is also attached
for your information.
Please contact me if you have any questions regarding this invitation.
Best regards,
Kei
---
Kei Ohno Woodall
Secretariat of the Basel, Rotterdam and Stockholm conventions
11-13 Chemin des Anémones
CH 1219 Châtelaine, Geneva
Tel.: +41 22 917 8201
Fax: +41 22 917 8098
Email: